US20140058223A1 - Sensor for percutaneous intravascular deployment without an indwelling cannula - Google Patents
Sensor for percutaneous intravascular deployment without an indwelling cannula Download PDFInfo
- Publication number
- US20140058223A1 US20140058223A1 US13/970,469 US201313970469A US2014058223A1 US 20140058223 A1 US20140058223 A1 US 20140058223A1 US 201313970469 A US201313970469 A US 201313970469A US 2014058223 A1 US2014058223 A1 US 2014058223A1
- Authority
- US
- United States
- Prior art keywords
- sensor
- patient
- cannula
- removable cannula
- glucose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A61B5/1459—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters invasive, e.g. introduced into the body by a catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14542—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring blood gases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/06—Body-piercing guide needles or the like
- A61M25/0662—Guide tubes
- A61M25/0668—Guide tubes splittable, tear apart
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Medical Informatics (AREA)
- Pathology (AREA)
- Optics & Photonics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Emergency Medicine (AREA)
- Pulmonology (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Abstract
The present invention relates to a sensor for percutaneous insertion and intravascular residence without an indwelling cannula. In preferred embodiments, a glucose sensor is inserted into a blood vessel using a removable cannula. After the cannula is removed, the glucose sensor remains within the blood vessel by itself and forms a seal with the patient's tissue.
Description
- Any and all applications for which a foreign or domestic priority claim is identified in the Application Data Sheet as filed with the present application are hereby incorporated by reference under 37 CFR 1.57.
- 1. Field of the Invention
- A sensor for intravascular residence is disclosed along with methods for percutaneous deployment of the sensor. In preferred embodiments, the sensor is a fiber-optic glucose sensor which is inserted and resides in a peripheral vein without an indwelling cannula.
- 2. Description of the Related Art
- Despite advances in glucose detection technologies, there are no minimally invasive, accurate, real-time, in vivo sensors on the market for monitoring glucose levels over a period of days or weeks. Consequently, it has been a significant burden on diabetics, patients and hospital staff to perform frequent blood sampling for conventional ex vivo blood glucose monitoring. There are short-term continuous glucose sensors that use enzyme-based glucose detection in the interstitial fluid. However, such sensors are relatively large, complex and expensive. These electrochemical sensors also consume reactants (e.g., glucose), which may become limiting particularly when the sensors are walled off due to the patient's foreign body reaction. Moreover, the equilibration lag time may change and the correlation between blood and interstitial glucose levels may become tenuous, particularly in seriously ill (e.g., ICU) patients.
- Intravascular sensor deployment raises other technical difficulties. Typically, one sensor for each analyte has been placed in a patient's blood vessel(s) through an indwelling cannula. If it is desired to measure several analytes, a plurality of sensors are often required, which can cause attendant discomfort to the patient and complexity of the electronic monitoring equipment. Moreover, even the deployment of a single sensor within a peripheral vein presents continuous maintenance issues for the nursing staff. The present state of the art is that sensors are deployed through indwelling cannulas. Because blood becomes trapped and clots within such cannulas and between the cannula and the sensor, the cannula must be flushed continuously or periodically, typically with saline/heparin. In the ICU, for example, the nursing staff regularly purge (e.g., every 4 hrs) the trapped blood and clots, to maintain cannula access to the vein open.
- Accordingly, there remains an important unmet need for a sensor configured for intravascular deployment and methods of deploying such a sensor, wherein the sensor by itself is left to reside within the vein, without any additional structural components (e.g., an indwelling cannula).
- A method is disclosed for deploying a sensor in a blood vessel of a patient. The method comprises positioning the sensor in the blood vessel, such that at least a distal portion of the sensor resides within the blood vessel and at least a proximal portion of the sensor extends out of the patient, wherein there are no additional components associated with the sensor within the patient.
- In one preferred embodiment, the blood vessel is a peripheral vein. In another preferred embodiment, the sensor is an optical fiber glucose sensor.
- In one embodiment, the step of positioning the sensor further comprises introducing the sensor into the blood vessel through an introducer assembly.
- In another embodiment, the step of positioning the sensor further comprises removing the introducer assembly, leaving only the sensor in the patient.
- A method for measuring an analyte concentration in a blood vessel is disclosed in accordance with another embodiment. The method comprises: providing a sensor configured to reside at least in part within the blood vessel and generate a signal related to the analyte concentration in the blood; introducing the sensor into the blood vessel through an introducer assembly; removing the introducer assembly, leaving only the analyte sensor in the patient; and detecting the signal to measure the analyte concentration in the blood.
- A method for deploying a sensor in a blood vessel is disclosed in accordance with another embodiment. The method comprises: providing an introducer assembly comprising a hypodermic needle slidably engaged within a splitable cannula, wherein a piercing tip of the hypodermic needle extends distally beyond the splitable cannula; cannulating the blood vessel with the introducer assembly; withdrawing the hypodermic needle, leaving the splitable cannula in the vessel; inserting the sensor through the splitable cannula and into the vessel; withdrawing the splitable cannula from the vessel, leaving the sensor in the vessel; and splitting and removing the cannula from the sensor.
- A method for continuous monitoring of blood glucose levels in a patient is disclosed in accordance with another embodiment. The method comprises: providing an introducer assembly comprising a hypodermic needle slidably engaged within a removable cannula, wherein a piercing tip of the hypodermic needle extends distally beyond the removable cannula; inserting the introducer assembly into a peripheral vein; retracting the hypodermic needle from the removable cannula, while leaving the removable cannula in the peripheral vein; providing an optical glucose sensor comprising a fluorescent indicator system disposed along a distal end region and adapted to generate an optical signal related to the blood glucose level in response to light, an elongate fiber-optic body, and an optical coupling disposed along a proximal end region; inserting the optical glucose sensor through the removable cannula and into the peripheral vein; retracting the removable cannula from the vein, while leaving the sensor in the peripheral vein; removing the removable cannula from the sensor; connecting the optical coupling to a device comprising a light source and a detector; and detecting the optical signal to monitor the blood glucose level of the patient. In one preferred embodiment, the removable cannula has at least one scoring such that the removable cannula can be split.
- For purposes of summarizing the invention, certain aspects, advantages and novel features of the invention are described herein. It is to be understood that not necessarily all such advantages may be achieved in accordance with any particular embodiment of the invention. Thus, for example, those skilled in the art will recognize that the invention may be embodied or carried out in a manner that achieves one advantage or group of advantages as taught herein without necessarily achieving other advantages as may be taught or suggested herein. These and other objects and advantages of the present invention will be more apparent from the following description taken in conjunction with the accompanying drawings.
-
FIG. 1 shows a side view of an embodiment of an intravascular sensor. -
FIG. 2 shows a side view of one embodiment of a peelable introducer. -
FIG. 3 shows a perspective view of one embodiment of a splitable introducer. -
FIG. 4A shows a back view of the splitable introducer ofFIG. 3 . -
FIG. 4B shows a side view of an introducer assembly comprising the splitable introducer ofFIG. 3 and a hypodermic needle. -
FIG. 5 shows a cut-away view of a sensor where a portion of the porous membrane sheath is cut away to expose the optical fiber and hydrogel beneath the membrane. -
FIG. 6 is a cross-sectional view along a longitudinal axis of a sensor with a hydrogel disposed distal the optical fiber. -
FIGS. 7A and 7B show blood glucose determinations in vitro in a circulating blood loop, with a comparison of the GLUCATH™ and YSI detection methods. -
FIGS. 8A and 8B show Bland-Altman difference plots comparing laboratory references to SURESTEP PRO FINGERSTICK™ and GLUCATH™ equilibrium fluorescent glucose sensor. The GLUCATH™ sensor is deployed in vivo in the right jugular vein of sheep. - In one embodiment, the present invention involves a method for deploying a sensor in a blood vessel of a patient, wherein the sensor resides within the patient without any additional device or structural components, e.g., introducer, cannula, catheter, sleeve, etc. The deployment of a naked, preferably very small and non-thrombogenic, sensor addresses some of the disadvantages that presently face patients and medical staff, e.g., thrombogenesis, constant staff care, etc. The sensor can be adapted to sense any analyte using known sensing systems and/or chemistries. The blood vessel can be an artery or a vein. The method comprises positioning the sensor in the blood vessel, such that a distal portion of the sensor resides within the blood vessel by itself, and a proximal portion of the sensor extends out of the patient, wherein there are no additional components associated with the sensor within the patient.
- More particularly, new and elegant solutions to some of the technical challenges faced by patients and medical staff in using existing in vivo glucose sensors are disclosed. In one embodiment, a solution to the technical challenges involves using a sensor comprising equilibrium, non-consuming fluorescence-based detection chemistry. Equilibrium optical sensing addresses the problems associated with rate-limiting consumption of enzymatic reactants in current electrochemical sensors. Further, placement within a peripheral vein, as opposed to subcutaneous (interstitial) placement, provides direct monitoring of blood glucose levels, thereby avoiding the problems associated with measuring glucose levels in the interstitial fluid—e.g., uncertain and changing equilibration time for glucose between the blood and the interstitial fluid. In another embodiment, deployment of a very small diameter, non-thrombogenic fiber-optic sensor within a vein, without an indwelling cannula, addresses the serious burden on the nursing staff related to continuous or periodic flushing of the cannula to maintain open access to the vein.
- Examples of small diameter, equilibrium optical sensors are disclosed in U.S. Pat. No. 6,627,177 and U.S. Patent Publ. No. 2006/0083688, and co-pending U.S. patent application Ser. Nos. 11/296,898; 11/782,553; 11/671,880; 12/027,158; 12/026,396; 60/917,309; 60/917,307; 60/954,204; 60/915,372; 60/949,145; and 60/989,732; each of which is incorporated herein in its entirety by reference thereto.
- Processes for inserting catheters into a blood vessel are known. Generally, a hypodermic needle is first inserted into the blood vessel. Once the hypodermic needle is in place in the blood vessel, a guidewire may be threaded through the hypodermic needle and into the blood vessel. After the guidewire has been inserted into the blood vessel through the hypodermic needle, the hypodermic needle can be removed, leaving the guidewire in place in the blood vessel. Next, a cannula is threaded over the guidewire and into the blood vessel. Finally, the guidewire is removed and the catheter is introduced into the blood vessel through the cannula. When the catheter is an analyte sensor, the cannula is left indwelling.
- In preferred embodiments, the present invention relates to a fiber-optic glucose sensor that is introduced into and resides within a blood vessel (or interstitial site) by itself, without an indwelling cannula or permanent introducer. The small diameter and flexibility of such a sensor provide obvious advantages in relation to patient comfort. Liao, K.-C., et al., Biosens. Bioelectron. (2008), doi: 10.1016/j.bios.2008.01.012 recently disclosed a smaller and less invasive glucose sensor designed for interstitial implantation, wherein glucose sensitivity is mediated by Con A binding and Quantum dots are used as FRET donors; the sensor chemistry is immobilized at the end of an optical fiber in a PEG-DA hydrogel. However, Liao et al., does not disclose intravascular deployment. Interstitial fluid is generally slow to equilibrate with glucose. Thus, intravascular monitoring is highly preferred because it is the glucose in blood that is important, particularly where patients are critically ill and the medical staff is trying to maintain tight glycemic control. Very sick patients tend to exhibit huge fluid shifts, which dramatically change glucose response time/correlation between blood glucose and interstitial fluid glucose.
- In some embodiments, e.g., for walking diabetics, interstitial deployment of an equilibrium fiber-optic sensor may be utilized. The equilibrium between blood and interstitial fluid glucose will tend to be relatively constant in such patients, wherein the convenience (less-invasive nature) of interstitial deployment may be preferred.
-
FIG. 1 shows an embodiment of asensor 10 having a distal end 12 and anelongate body 14 that can be percutaneously inserted into a blood vessel, such as a vein or artery, for intravascular residence. In some embodiments, the vein or artery can be a peripheral vein or a peripheral artery, while in other embodiments, the vein or artery can be a central vein or a central artery. In some embodiments, the sensor can be interstitially deployed. Thesensor 10 can be a sensor for measuring any compound, metabolite, chemical, protein, molecule, nutrient, and/or hemodynamic parameter of interest. For example, thesensor 10 can be a sensor for measuring glucose, ions such as potassium, blood gases, such as oxygen and carbon dioxide, flow rate, pressure, pH, or any other measurable analyte. In some embodiments, as illustrated inFIG. 1 , thesensor 10 is a fiber-optic glucose sensor as further described in co-pending U.S. application Ser. Nos. 12/026,396, filed Feb. 5, 2008 and U.S. application Ser. No. 12/027,158, filed Feb. 6, 2008, both of which are incorporated herein by reference in their entireties. - The
sensor 10 can be percutaneously introduced into a blood vessel by using aremovable introducer 20, embodiments of which are illustrated inFIGS. 2-4 . Theintroducer 20 can be, for example, peelable or splitable. One embodiment of apeelable introducer 20 is shown inFIG. 2 . Theintroducer 20 has adistal end 22, aproximal end 24 and anelongate body 26 having a lumen therebetween. In some embodiments, theelongate body 26 can be a sheath or tubular structure with thin walls. Theproximal end 24 comprises ahub 27 having afirst wing 28 and asecond wing 30 that extend transversely away from theelongate body 26. Thefirst wing 28 andsecond wing 30 are located opposite or substantially opposite each other. Theelongate body 26 can have twolongitudinal score lines elongate body 26 into two halves, each half attached to a wing. The score lines 32, 34 are weakened portions of theelongate body 26 that allow theintroducer 20 to be split in half by grasping thewings wings -
FIGS. 3 and 4A and 4B illustrate an embodiment of asplitable introducer 20. As shown inFIG. 3 , the splitable introducer 20 has adistal end 22, aproximal end 24 and anelongate body 26 having alumen 36 therebetween. Theproximal end 24 comprises ahub 27 having afirst wing 28 and asecond wing 30 that extend transversely away from theelongate body 26. As shown inFIG. 4A , thefirst wing 28 and thesecond wing 30 can be attached to thehub 27 at an angle α to each other. In some embodiments, the angle α between thefirst wing 28 and thesecond wing 30 is less than about 120 degrees. - As shown in
FIG. 3 , the splitable introducer 20 has asingle score line 32 that runs along the length of theelongate body 26 andhub 27. Thescore line 32 is located on a portion of the splitable introducer 20 that generally opposes thefirst wing 28 and thesecond wing 30. For example, as shown inFIG. 4A , the splitable introducer 20 can be divided in half longitudinally by plane P which also bisects angle α. Thescore line 32 is located at an angle γ from thefirst wing 28 and at an angle β from the second wing. In some embodiments, β and γ are approximately equal. In some embodiments, β and γ are at least about 120 degrees. The splitable introducer 20 can be split along thescore line 32 by squeezing thefirst wing 28 and thesecond wing 30 together. In some embodiments, squeezing can advantageously be accomplished by using just one hand. -
FIG. 4B illustrates anintroducer assembly 40 comprising asplitable introducer 20 and a hypodermic needle 42 disposed therein. The hypodermic needle 42 has adistal end 44 and aproximal end 46 and acannula 48 extending therebetween. Thedistal end 44 of thecannula 48 can be beveled to terminate in a sharp point that facilitates entry of the hypodermic needle 42 into the patient's tissue. The proximal portion of the hypodermic needle can include afilter 50 andflashback chamber 52. When thedistal end 44 of the hypodermic need 42 is inserted into a blood vessel or interstitial space, blood or interstitial fluid will fill theflashback chamber 52, thereby facilitating the correct placement of theintroducer assembly 40 into the blood vessel. Thefilter 50 can function to contain the blood within theflashback chamber 52 and to reduce the likelihood of contamination of the blood, thereby reducing the chance of infection. As illustrated, thecannula 48 is removably disposed within thelumen 36 of theelongate body 26 of thesplitable introducer 20. After theintroducer assembly 40 is inserted in the blood vessel or interstitial space, the hypodermic needle 42 can be withdrawn from thesplitable introducer 20, leaving just thesplitable introducer 20 in the blood vessel or interstitial space. - Additional types of
removable introducers 20 are also suitable for introducing thesensor 10 into a blood vessel. For example, anintroducer 20 that can be removed by cutting can be used in some embodiments. The cutting tool used to cut theintroducer 20 can be designed to cut theintroducer 20 without damaging thesensor 10 underneath. - In some embodiments, the
introducer 20 can be made out of a metal, metal alloy, resin (for example, a thermosetting resin such as an epoxy resin or phenolic resin), polymer (for example, a thermoplastic polymer or, in some cases, an elastomeric polymer) or a combination of the forgoing compounds. The polymer can be polyacrylate, polyurethane, polysulfone, polypropylene, polytetrafluoroethylene, polyethylene, polystyrene, polymethyl methacrylate, polycarbonate, polyethylene terephthalate, polyvinyl chloride, or any other suitable polymer. In certain embodiments, the introducer comprises polyurethane. - Examples of removable introducers that can be used in accordance with some embodiments are described in U.S. Pat. Nos. 4,345,606, 5,141,497, 5,334,157, 5,409,469, 6,273,874, and 6,663,595, and EP 0402057B1; each of which is incorporated herein in its entirety by reference thereto.
- In some embodiments, an introducer assembly comprises an introducer with a hypodermic needle coaxially engaged within the lumen of the introducer. The hypodermic needle or stylus is typically within the lumen of the
introducer 20 before theintroducer 20 is inserted into the patient to access the patient's blood vessel or interstitial site. The distal end of the hypodermic needle or stylus can extend beyond thedistal end 22 of theintroducer 20 so that the hypodermic needle or stylus can help theintroducer 20 penetrate the patient's tissue to access the blood vessel. In addition, the hypodermic needle can help the medical practitioner locate the blood vessel by allowing the medical practitioner to visualize blood when the hypodermic needle enters a blood vessel. It is understood that any member capable of piercing the skin and traversing the underlying tissue can be used in accordance with embodiments of the invention—it need not be a “hypodermic needle” per se. In one embodiment, the introducer itself may comprise a beveled or otherwise piercing distal end that is splitable, peelable, etc., such that a separate needle need not be used to access the blood vessel or interstitial site. - In some embodiments, the hypodermic needle has a diameter that is only slightly less than the diameter of the
elongate body 26 of theintroducer 20. This can be accomplished by making the walls of theelongate body 26 relatively thin. In addition, the hypodermic needle can have a diameter that is only slightly less than thelumen 36 of theintroducer 20 so that the hypodermic needle fits snugly into thelumen 36. In some embodiments, thedistal end 22 of theintroducer 20 can be beveled or tapered to provide a gradual increase in diameter of the distal portion of theelongate body 26. In some embodiments, e.g., where a metal needle and a stretchable polymeric introducer are employed, the diameter of the needle may be equal to or even larger than the diameter of the introducer, such that the introducer expands to accommodate the needle. - The hypodermic needle, which projects past the
distal end 22 of theintroducer 20, is used to puncture the skin and tissue of the patient, creating a hole with a diameter substantially equal to the diameter of the hypodermic needle. As the hypodermic needle andintroducer 20 are advanced through the patient's tissue and into the blood vessel or interstitial site, thedistal end 22 of theintroducer 20 enters the hole made by the hypodermic needle. As described above, in some embodiments the beveled or tapereddistal end 22 facilitates insertion of theelongate body 26 of theintroducer 20 into the hole made by the hypodermic needle by closely matching the diameter of thedistal end 22 to the diameter of the hole. The beveled or tapereddistal end 22 also allows the hole to be gradually stretched wider, rather than further cutting or tearing the tissue, as the introducer is advanced. The wall of theelongate body 26 can be thin in order to reduce the degree of widening of the hole that occurs as the introducer is advanced. In addition, the gradual widening or stretching of the hole facilitates the formation of a tight seal between the patient's tissue and theelongate body 26. - After the
introducer 20 is inserted into the blood vessel, the hypodermic needle or stylus can be removed from thelumen 36 of theintroducer 20. In some embodiments, theelongate body 26 can be flexible and kink resistant. Theelongate body 26 can be made flexible by fabricating theelongate body 26 out of a polymer such as polyacrylate, polyurethane, polysulfone, polypropylene, polytetrafluoroethylene, polyethylene, polystyrene, polymethyl methacrylate, polycarbonate, polyethylene terephthalate, polyvinyl chloride, or any other suitable polymer. Theelongate body 26 can be made stiff, while maintaining its flexibility, and kink resistant by embedding or incorporating a coil of wire into the polymerelongate body 26. This is especially true for elastomeric polymers, such as polyacrylate and polyurethane. Preferably, the wire is very thin and can be made out of a variety of metals or metal alloys, such as steel, nickel, titanium, aluminum or a combination of each. However, in some embodiments, theelongate body 26 does not comprise a coil of wire. Making theelongate body 26 flexible and kink resistant reduces the likelihood that thelumen 36 will kink or collapse, which can make insertion of thesensor 10 through theintroducer 20 difficult. - The
sensor 10, a fiber-optic glucose sensor in preferred embodiments, can be inserted into thelumen 36 of theintroducer 20 and into the blood vessel. In some embodiments, thesensor 10 has a diameter that is the same as or substantially similar to the diameter of the hypodermic needle or to the inner diameter of thelumen 36 of theintroducer 20. Thesensor 10 can have a smooth surface to facilitate passage of thesensor 10 through thelumen 36 of theintroducer 20. In some embodiments, a lubricant can be used to facilitate passage of thesensor 10 through thelumen 36 of theintroducer 20. - After the
sensor 10 has been introduced into the blood vessel or interstitial site through thelumen 36 of theintroducer 20, theintroducer 20 can be withdrawn from the patient's tissue. Theintroducer 20 can be removed from thesensor 10 by peeling, splitting or cutting theintroducer 20, as described above. - Once the
introducer 20 has been removed, the stretched hole closes around thesensor 10, forming a seal. The surface of thesensor 10 can be made smooth to enhance the seal between the patient's tissue and the surface of thesensor 10. This allows thesensor 10 to reside in the blood vessel or interstitial site without using a permanent indwelling cannula that also resides in the blood vessel or interstitial site. - In some embodiments, the
sensor 10 can be given anti-thrombogenic properties by, for example, coating or treating the surface of thesensor 10 with heparin or another compound with anti-thrombogenic properties. In addition, thesensor 10 can be fabricated with a smooth surface having low thrombogenicity. For example, thesensor 10 surface can be made of a polymer such as polytetrafluoroethylene. Portions of thesensor 10 that include a porous or semipermeable membrane can be given a smooth surface by the polymerization of a polymer, such as a hydrogel, within the pores of the membrane, as described in co-pending U.S. application Ser. No. 12/026,396, filed Feb. 5, 2008, which is hereby incorporated by reference in its entirety. - In some embodiments, a fiber-optic glucose sensor can be inserted into a blood vessel or an interstitial space of the patient as described herein. The glucose sensor comprises an optical glucose measurement system that measures glucose concentration levels using glucose-sensing chemical indicator systems. Such indicator systems preferably comprise a fluorophore operably coupled to a glucose binding moiety. Preferably, the glucose binding moiety acts as a quencher with respect to the fluorophore (e.g., suppresses the fluorescent emission signal of the fluorophore in response to excitation light when it associates with the fluorophore). In preferred embodiments, as the glucose binding moiety binds glucose (e.g., as glucose concentrations rise), it dissociates from the fluorophore, which then generates a fluorescent emission signal upon excitation. Accordingly, in such embodiments, the higher the glucose concentration, the more glucose bound by the binding moiety, the less quenching, and the higher the fluorescence intensity of the fluorophore upon excitation.
- The optical glucose measurement system measures, in certain embodiments, the glucose concentrations intravascularly or interstitially and in real-time through the use of such fluorophore-quencher indicator systems. The glucose-sensing indicator systems can be immobilized in a hydrogel. The hydrogel can be inserted into an optical fiber such that light may be transmitted through the hydrogel while at least a portion of the hydrogel is in contact with blood. The hydrogel is preferably permeable to analytes, specifically glucose. The optical fiber together with the hydrogels can comprise a glucose sensor that is placed in a mammalian (human or animal) blood vessel or interstitial space. In certain embodiments, light is transmitted into the glucose sensor from a light source. The light source can be a light emitting diode that emits an optical excitation signal. The optical excitation signal can excite the fluorophore systems in the presence of glucose, such that the fluorophores emit light at an emission wavelength. In certain embodiments, the fluorophore systems can be configured to emit an optical emission signal at a first wavelength having an intensity related to the blood glucose concentration in the blood vessel or the interstitial fluid glucose concentration in the interstitial space. The light can be directed out of the glucose sensor such that the light is detected by a light sensitive module (or detector system) that can comprise at least one detector. Detectors include any component capable of converting light into a measurable signal, and may include but are not limited to photomultipliers, photodiodes, diode arrays, or the like. The at least one detector can be configured to measure the intensity of the emission wavelength because the intensity of the emission wavelength, in certain embodiments, is related to the glucose concentration present in the blood. In certain embodiments, the light sensitive module (or detector system) comprises an interference filter, an amplifier, and/or an analog-to-digital converter. The light sensitive module (or detector system) can also comprise a microspectrometer, spectrometer, or the like.
- Various non-glucose related factors can affect the measurements of the intensity of the emission wavelength, resulting in measurement errors. In certain embodiments, the measurement errors are eliminated or are substantially eliminated or reduced by employing a ratio of certain signals. The measurement errors that may be eliminated include but are not limited to changes in the intensity of the light generated from the light source(s), changes in the coupling efficiency of light into the optical fibers, bending of the optical fiber and the ensuing loss of light from the fiber, changes in the sensitivity of the detection circuit due to, for example, temperature or age or duration of use. In certain embodiments, the ratio of certain signals is unaffected by changes in the light source intensity, the coupling efficiency of the light source into the optical fibers, bending of the optical fibers or the like. The ratio of certain signals can be the ratio of an emission signal to an excitation signal. In certain embodiments, the ratio of certain signals is the ratio of an emission signal to a second optical signal. The second signal may be the excitation light signal which is transmitted through the optical system, through the sensor and indicator system, and reflects back at least in part from the sensor into the light sensitive module (or detector system). Alternatively, the second signal may be generated by a separate reference light, for example red light, which is not absorbed by the indictor system. The second signal may be generated by certain fluorophores as a second emission signal at a different wavelength—the intensity of which is independent of glucose. Any light that is propagated through the optical system, can be either not altered by the glucose concentration or is the excitation light. Light not altered by the glucose concentration can be detected by the light sensitive system (or detector system) and may be used as the second or reference light signal.
- From the disclosure herein, it will be apparent to those of ordinary skill in the art that other sources of measurement errors may also be eliminated by employing a ratio of certain signals.
- The indicator system (also referred to herein as a fluorophore system) can comprise a fluorophore operably coupled to a quencher. In certain embodiments, the fluorophore system comprises a polymer matrix comprising a fluorophore susceptible to quenching by a viologen, a viologen quencher with quenching efficacy dependent on glucose concentration, and a glucose permeable polymer, wherein said matrix is in contact with blood in vivo. Preferably the fluorophore is a fluorescent organic dye, the quencher is a boronic acid functionalized viologen, and the matrix is a hydrogel.
- “Fluorophore” refers to a substance that when illuminated by light at a particular wavelength emits light at a longer wavelength; i.e. it fluoresces. Fluorophores include but are not limited to organic dyes, organometallic compounds, metal chelates, fluorescent conjugated polymers, quantum dots or nanoparticles and combinations of the above. Fluorophores may be discrete moieties or substituents attached to a polymer.
- Fluorophores that may be used in preferred embodiments are capable of being excited by light of wavelength at or greater than about 400 nm, with a Stokes shift large enough that the excitation and emission wavelengths are separable by at least 10 nm. In some embodiments, the separation between the excitation and emission wavelengths may be equal to or greater than about 30 nm. These fluorophores are preferably susceptible to quenching by electron acceptor molecules, such as viologens, and are resistant to photo-bleaching. They are also preferably stable against photo-oxidation, hydrolysis and biodegradation.
- In some embodiments, the fluorophore may be a discrete compound.
- In some embodiments, the fluorophore may be a pendant group or a chain unit in a water-soluble or water-dispersible polymer having molecular weight of about 10,000 daltons or greater, forming a dye-polymer unit. In one embodiment, such dye-polymer unit may also be non-covalently associated with a water-insoluble polymer matrix M1 and is physically immobilized within the polymer matrix M1, wherein M1 is permeable to or in contact with an analyte solution. In another embodiment, the dye on the dye-polymer unit may be negatively charged, and the dye-polymer unit may be immobilized as a complex with a cationic water-soluble polymer, wherein said complex is permeable to or in contact with the analyte solution. In one embodiment, the dye may be one of the polymeric derivatives of hydroxypyrene trisulfonic acid. The polymeric dyes may be water-soluble, water-swellable or dispersible in water. In some embodiments, the polymeric dyes may also be cross-linked. In preferred embodiments, the dye has a negative charge.
- In other embodiments, the dye molecule may be covalently bonded to the water-insoluble polymer matrix M1, wherein said M1 is permeable to or in contact with the analyte solution. The dye molecule bonded to M1 may form a structure M1-L1-Dye. L1 is a hydrolytically stable covalent linker that covalently connects the sensing moiety to the polymer or matrix. Examples of L1 include lower alkylene (e.g., C1-C8 alkylene), optionally terminated with or interrupted by one or more divalent connecting groups selected from sulfonamide (—SO2NH—), amide —(C═O)N—, ester —(C═O)—O—, ether.-O—, sulfide —S—, sulfone (—SO2—), phenylene —C6H4—, urethane —NH(C═O)—O—, urea —NH(C═O)NH—, thiourea —NH(C═S)—NH—, amide —(C═O)NH—, amine —NR— (where R is defined as alkyl having 1 to 6 carbon atoms) and the like, or a combination thereof. In one embodiment, the dye is bonded to a polymer matrix through the sulfonamide functional groups.
- In accordance with broad aspects of the present invention, the analyte binding moiety provides the at least dual functionality of being able to bind analyte and being able to modulate the apparent concentration of the fluorophore (e.g., detected as a change in emission signal intensity) in a manner related to the amount of analyte binding. In preferred embodiments, the analyte binding moiety is associated with a quencher. “Quencher” refers to a compound that reduces the emission of a fluorophore when in its presence. Quencher (Q) is selected from a discrete compound, a reactive intermediate which is convertible to a second discrete compound or to a polymerizable compound or Q is a pendant group or chain unit in a polymer prepared from said reactive intermediate or polymerizable compound, which polymer is water-soluble or dispersible or is an insoluble polymer, said polymer is optionally crosslinked.
- In one example, the moiety that provides glucose recognition in the embodiments is an aromatic boronic acid. The boronic acid is covalently bonded to a conjugated nitrogen-containing heterocyclic aromatic bis-onium structure (e.g., a viologen). “Viologen” refers generally to compounds having the basic structure of a nitrogen containing conjugated N-substituted heterocyclic aromatic bis-onium salt, such as 2,2′-, 3,3′- or 4,4′-N,N′bis-(benzyl) bipyridium dihalide (i.e., dichloride, bromide chloride), etc. Viologen also includes the substituted phenanthroline compounds. The boronic acid substituted quencher preferably has a pKa of between about 4 and 9, and reacts reversibly with glucose in aqueous media at a pH from about 6.8 to 7.8 to form boronate esters. The extent of reaction is related to glucose concentration in the medium. Formation of a boronate ester diminishes quenching of the fluorphore by the viologen resulting in an increase in fluorescence dependent on glucose concentration. A useful bis-onium salt is compatible with the analyte solution and capable of producing a detectable change in the fluorescent emission of the dye in the presence of the analyte to be detected.
- Bis-onium salts in the embodiments of this invention are prepared from conjugated heterocyclic aromatic di-nitrogen compounds. The conjugated heterocyclic aromatic di-nitrogen compounds are selected from dipyridyls, dipyridyl ethylenes, dipyridyl phenylenes, phenanthrolines, and diazafluorenes, wherein the nitrogen atoms are in a different aromatic ring and are able to form an onium salt. It is understood that all isomers of said conjugated heterocyclic aromatic di-nitrogen compounds in which both nitrogens can be substituted are useful in this invention. In one embodiment, the quencher may be one of the bis-onium salts derived from 3,3′-dipyridyl, 4,4′-dipyridyl and 4,7-phenanthroline.
- In some embodiments, the viologen-boronic acid adduct may be a discrete compound having a molecular weight of about 400 daltons or greater. In other embodiments, it may also be a pendant group or a chain unit of a water-soluble or water-dispersible polymer with a molecular weight greater than about 10,000 daltons. In one embodiment, the quencher-polymer unit may be non-covalently associated with a polymer matrix and is physically immobilized therein. In yet another embodiment, the quencher-polymer unit may be immobilized as a complex with a negatively charge water-soluble polymer.
- In other embodiments, the viologen-boronic acid moiety may be a pendant group or a chain unit in a crosslinked, hydrophilic polymer or hydrogel sufficiently permeable to the analyte (e.g., glucose) to allow equilibrium to be established.
- In other embodiments, the quencher may be covalently bonded to a second water-insoluble polymer matrix M2, which can be represented by the structure M2-L2-Q. L2 is a linker selected from the group consisting of a lower alkylene (e.g., C1-C8 alkylene), sulfonamide, amide, quaternary ammonium, pyridinium, ester, ether, sulfide, sulfone, phenylene, urea, thiourea, urethane, amine, and a combination thereof. The quencher may be linked to M2 at one or two sites in some embodiments.
- In certain embodiments, at least one quencher precursor is used to attach the quenching moiety to at least one polymer. For example, aromatic groups may be used to functionalize a viologen with combinations of boronic acid groups and reactive groups. In certain embodiments, this process includes attaching an aromatic group to each of the two nitrogens in the dipyridyl core of the viologen. At least one boronic acid group, a reactive group, or a combination of the two are then attached to each aromatic group, such that the groups attached to each of the two nitrogens on the dipyridyl core of the viologen may either be the same or different. Certain combinations of the functionalized viologen quenching moiety are described as follows:
- a) a first aromatic group having a pendent reactive group is attached to the first nitrogen and a second aromatic group having at least one pendent boronic group is attached to the second nitrogen;
- b) one or more boronic acid groups are attached to a first aromatic group, which is attached to the first nitrogen, and one boronic acid group and a reactive group are attached to a second aromatic group, which second aromatic group is attached to the second nitrogen;
- c) one boronic acid group and a reactive group are attached to a first aromatic group, which first aromatic group is attached to the first nitrogen, and one boronic acid group and a reactive group are attached to a second aromatic group, which is attached to the second nitrogen; and
- d) one boronic acid group is attached to an aromatic group, which aromatic group is attached to each of the two nitrogens, and a reactive group is attached to a carbon in a heteroaromatic ring in the heteroaromatic centrally located group.
- Preferred embodiments comprise two boronic acid moieties and one polymerizable group or coupling group wherein the aromatic group is a benzyl substituent bonded to the nitrogen and the boronic acid groups are attached to the benzyl ring and may be in the ortho- meta- or para-positions.
-
FIG. 5 shows an embodiment of the distal portion of asensor 100 comprising anoptical fiber 110 with adistal end 112 disposed in aporous membrane sheath 114. Theoptical fiber 110 hascavities 106, such as holes, in the fiber-optic wall that can be formed by, for example, mechanical means such as drilling or cutting. Thecavities 106 in theoptical fiber 110 can be filled with a suitable compound, such as a polymer. In some embodiments, the polymer is ahydrogel 108. In other embodiments of thesensor 100 as shown inFIG. 6 , theoptical fiber 110 does not havecavities 106, and instead, thehydrogel 108 is disposed in a space distal to thedistal end 112 of theoptical fiber 110 and proximal to themirror 123. In some embodiments, thesensor 100 is a glucose sensor. In some embodiments, the glucose sensor is an intravascular or interstitial glucose sensor. - In some embodiments, the
porous membrane sheath 114 can be made from a polymeric material such as polyethylene, polycarbonate, polysulfone or polypropylene. Other materials can also be used to make theporous membrane sheath 114 such as zeolites, ceramics, metals, or combinations of these materials. In some embodiments, theporous membrane sheath 114 is microporous and has a mean pore size that is less than approximately two nanometers. In other embodiments, theporous membrane sheath 114 is mesoporous and has a mean pore size that is between approximately two nanometers to approximately fifty nanometers. In still other embodiments, theporous membrane sheath 114 is macroporous and has a mean pore size that is greater than approximately fifty nanometers. - In some embodiments as shown in
FIG. 6 , theporous membrane sheath 114 is attached to theoptical fiber 110 by aconnector 116. For example, theconnector 116 can be an elastic collar that holds theporous membrane sheath 114 in place by exerting a compressive force on theoptical fiber 110. In other embodiments, theconnector 116 is an adhesive or a thermal weld. - In some embodiments as shown in
FIG. 5 , amirror 123 andthermistor 125 can be placed within theporous membrane sheath 114 distal thedistal end 112 of theoptical fiber 110. Thermistor leads 127 can be made to run in a space between theoptical fiber 110 andporous membrane sheath 114. Although athermistor 125 is shown, other devices such as a thermocouple, pressure transducer, an oxygen sensor, a carbon dioxide sensor or a pH sensor for example can be used instead. - In some embodiments as shown in
FIG. 6 , thedistal end 118 of theporous membrane sheath 114 is open and can be sealed with, for example, an adhesive 120. In some embodiments, the adhesive 120 can comprise a polymerizable material that can fill thedistal end 118 and then be polymerized into a plug. Alternatively, in other embodiments thedistal end 118 can be thermally welded by melting a portion of the polymeric material on thedistal end 118, closing the opening and allowing the melted polymeric material to resolidify. In other embodiments as shown inFIG. 5 , apolymeric plug 121 can be inserted into thedistal end 118 and thermally heated to weld the plug to theporous membrane sheath 114. Thermoplastic polymeric materials such as polyethylene, polypropylene, polycarbonate and polysulfone are particularly suited for thermal welding. In other embodiments, thedistal end 118 of theporous membrane sheath 114 can be sealed against theoptical fiber 110. - With reference to
FIGS. 7A and B, the results of glucose determination over time and with infused glucose in a circulating blood loop in vitro are compared for a continuous glucose sensor in accordance with a preferred embodiment of the present invention (-GLUCATH™) and the Yellow Springs Instrument glucose oxidase lab analyzer ( YSI), the gold standard of blood glucose measurements. The GLUCATH™ equilibrium fluorescence glucose sensor used in this experiment comprised HPTS-triCysMA dye and 3,3′-oBBV quencher.FIG. 7A shows an 8 hr time course with changes in circulating glucose in the range of 50-400 mg/dl.FIG. 7B is an expanded illustration of the two hr stepwise addition of 10 mg/dl boluses. The data show that the equilibrium fluorescence glucose sensor provides continuous monitoring of blood glucose which is as accurate as the YSI lab analyzer. The expanded view inFIG. 7B shows rapid and accurate sensing even at very low levels of blood glucose (between 50 and 100 mg/dl). This is surprising since accurate detection in such a low range has been extremely difficult to accomplish with other detection devices. The lack of accurate and reliable blood glucose sensing below 100 mg/dl has hampered ICU attempts to maintain target blood glucose levels, because of the significant clinical risk of going too low. - With reference to
FIGS. 8A and B, Bland-Altman plots show differences between laboratory references and either fingerstick POC (FIG. 8A ) or GLUCATH™ indwelling equilibrium fluorescence glucose sensor (FIG. 8B ) for in vivo blood glucose monitoring.FIG. 8A shows results of blood glucose detection using a standard fingerstick test compared to a clinical chemistry system. The 95% confidence limits vary from −22.7 to 28.4 mg/dl with a bias of 2.1 mg/dl. It is noteworthy that very few readings below 100 mg/dl can be seen.FIG. 8B shows results of blood glucose detection using GLUCATH™ continuous equilibrium fluorescence glucose sensor, deployed intravascularly in sheep compared to the YSI lab analyzer. The differences are much tighter, with 95% confidence limits of −11.7 to 14.1 mg/dl and a bias of only 1.2 mg/dl. There are many more data points below 100 mg/dl. - The invention may be embodied in other specific forms without departing from its spirit or essential characteristics. The described embodiments are to be considered in all respects only as illustrative and not restrictive. The scope of the invention is therefore indicated by the appended claims rather than the foregoing description. All changes that come within the meaning and range of equivalency of the claims are to be embraced within their scope.
Claims (22)
1-35. (canceled)
36. A method for introducing an analyte sensor into a patient, comprising:
providing an introducer assembly comprising a piercing member associated with a removable cannula, wherein a piercing tip of the piercing member extends distally beyond the removable cannula;
inserting the introducer assembly into the patient;
retracting the piercing member from the removable cannula, while leaving the removable cannula in the patient;
providing an optical analyte sensor comprising a fluorescent indicator system disposed along a distal end region and adapted to generate an optical signal related to the patient's analyte level in response to light, an elongate optical fiber, and an optical coupling disposed along a proximal end region;
inserting the optical analyte sensor through the removable cannula and into the patient;
retracting the removable cannula from the patient, while leaving the sensor in the patient; and
removing the removable cannula from the sensor.
37. The method of claim 36 , wherein the optical analyte sensor comprises an anti-thrombogenic coating or surface treatment.
38. The method of claim 36 , wherein the optical analyte sensor has a surface comprising polytetrafluoroethylene.
39. The method of claim 36 , wherein removing the removable cannula comprises at least one of splitting the removable cannula, peeling the removable cannula, and cutting the removable cannula.
40. The method of claim 39 , wherein removing the removable cannula comprises squeezing a first wing and a second wing together, wherein the first wing and the second wing are disposed opposite each other along a longitudinal axis of the removable cannula.
41. The method of claim 36 , wherein the piercing member is inserted into a blood vessel and the introducer assembly comprises a flashback chamber, wherein the flashback chamber fills with blood when the blood vessel is cannulated.
42. The method of claim 41 , wherein the introducer assembly comprises a filter, wherein the filter contains the blood within the flashback chamber when the blood vessel is cannulated.
43. The method of claim 36 , wherein the piercing member has a diameter less than a diameter of the removable cannula.
44. The method of claim 36 , wherein the removable cannula has a proximal end and a distal end, wherein the distal end of the cannula is beveled.
45. The method of claim 36 , wherein withdrawing the removable cannula from the patient while leaving the sensor in the patient forms a seal around the sensor.
46. The method of claim 36 , wherein the chemical indicator system comprises a fluorophore configured to generate an emission signal in response to excitation light, and an analyte binding moiety operably coupled to the fluorophore, wherein the analyte binding moiety is configured to bind analyte and modulate the emission signal of the fluorophore in a manner related to the amount of analyte binding.
47. The method of claim 46 , wherein the chemical indicator system further comprises a water-insoluble polymer matrix, and wherein the fluorophore is covalently bonded to the polymer matrix.
48. The method of claim 46 , wherein the analyte binding moiety comprises an aromatic boronic acid covalently bonded to the viologen.
49. The method of claim 36 , wherein the optical analyte sensor further comprises a porous membrane disposed along the distal end region of the optical fiber.
50. The method of claim 49 , wherein the porous membrane can comprise a material selected from the group consisting of polyethylene, polycarbonate, polysulfone, and polypropylene.
51. The method of claim 49 , wherein the porous membrane is microporous and has a mean pore size that is less than two nanometers.
52. The method of claim 46 , wherein the fluorophore comprises HPTS-triCysMA and the analyte binding moiety comprises 3-3′-oBBV.
53. The method of claim 36 , wherein the piercing member is deployed in an interstitial site, interstitial fluid, or interstitial space of the patient.
54. The method of claim 36 , wherein the optical analyte sensor comprises a thermistor or thermocouple disposed along the distal end region of the optical fiber.
55. The method of claim 36 , wherein the piercing member is a hypodermic needle.
56. The method of claim 36 , wherein the piercing member is a part of the removable cannula.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/970,469 US20140058223A1 (en) | 2008-04-17 | 2013-08-19 | Sensor for percutaneous intravascular deployment without an indwelling cannula |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4588708P | 2008-04-17 | 2008-04-17 | |
US12/424,902 US8512245B2 (en) | 2008-04-17 | 2009-04-16 | Sensor for percutaneous intravascular deployment without an indwelling cannula |
US13/970,469 US20140058223A1 (en) | 2008-04-17 | 2013-08-19 | Sensor for percutaneous intravascular deployment without an indwelling cannula |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/424,902 Continuation US8512245B2 (en) | 2008-04-17 | 2009-04-16 | Sensor for percutaneous intravascular deployment without an indwelling cannula |
Publications (1)
Publication Number | Publication Date |
---|---|
US20140058223A1 true US20140058223A1 (en) | 2014-02-27 |
Family
ID=40756449
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/424,902 Active 2032-06-20 US8512245B2 (en) | 2008-04-17 | 2009-04-16 | Sensor for percutaneous intravascular deployment without an indwelling cannula |
US13/970,469 Abandoned US20140058223A1 (en) | 2008-04-17 | 2013-08-19 | Sensor for percutaneous intravascular deployment without an indwelling cannula |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/424,902 Active 2032-06-20 US8512245B2 (en) | 2008-04-17 | 2009-04-16 | Sensor for percutaneous intravascular deployment without an indwelling cannula |
Country Status (2)
Country | Link |
---|---|
US (2) | US8512245B2 (en) |
WO (1) | WO2009129186A2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20180368774A1 (en) * | 2017-06-23 | 2018-12-27 | Dexcom, Inc. | Transcutaneous analyte sensors, applicators therefor, and associated methods |
USD926325S1 (en) | 2018-06-22 | 2021-07-27 | Dexcom, Inc. | Wearable medical monitoring device |
US11331022B2 (en) | 2017-10-24 | 2022-05-17 | Dexcom, Inc. | Pre-connected analyte sensors |
US11350862B2 (en) | 2017-10-24 | 2022-06-07 | Dexcom, Inc. | Pre-connected analyte sensors |
Families Citing this family (96)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7899511B2 (en) | 2004-07-13 | 2011-03-01 | Dexcom, Inc. | Low oxygen in vivo analyte sensor |
US8527026B2 (en) | 1997-03-04 | 2013-09-03 | Dexcom, Inc. | Device and method for determining analyte levels |
US9155496B2 (en) | 1997-03-04 | 2015-10-13 | Dexcom, Inc. | Low oxygen in vivo analyte sensor |
US6862465B2 (en) | 1997-03-04 | 2005-03-01 | Dexcom, Inc. | Device and method for determining analyte levels |
US6001067A (en) | 1997-03-04 | 1999-12-14 | Shults; Mark C. | Device and method for determining analyte levels |
US7192450B2 (en) | 2003-05-21 | 2007-03-20 | Dexcom, Inc. | Porous membranes for use with implantable devices |
US8480580B2 (en) | 1998-04-30 | 2013-07-09 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US6175752B1 (en) | 1998-04-30 | 2001-01-16 | Therasense, Inc. | Analyte monitoring device and methods of use |
US6949816B2 (en) | 2003-04-21 | 2005-09-27 | Motorola, Inc. | Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same |
US8465425B2 (en) | 1998-04-30 | 2013-06-18 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8346337B2 (en) | 1998-04-30 | 2013-01-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9066695B2 (en) | 1998-04-30 | 2015-06-30 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8974386B2 (en) | 1998-04-30 | 2015-03-10 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8688188B2 (en) | 1998-04-30 | 2014-04-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US6560471B1 (en) | 2001-01-02 | 2003-05-06 | Therasense, Inc. | Analyte monitoring device and methods of use |
US20030032874A1 (en) | 2001-07-27 | 2003-02-13 | Dexcom, Inc. | Sensor head for use with implantable devices |
US6702857B2 (en) | 2001-07-27 | 2004-03-09 | Dexcom, Inc. | Membrane for use with implantable devices |
US9282925B2 (en) | 2002-02-12 | 2016-03-15 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
US7828728B2 (en) | 2003-07-25 | 2010-11-09 | Dexcom, Inc. | Analyte sensor |
US8260393B2 (en) | 2003-07-25 | 2012-09-04 | Dexcom, Inc. | Systems and methods for replacing signal data artifacts in a glucose sensor data stream |
US9247901B2 (en) | 2003-08-22 | 2016-02-02 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
US8010174B2 (en) | 2003-08-22 | 2011-08-30 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
US7134999B2 (en) | 2003-04-04 | 2006-11-14 | Dexcom, Inc. | Optimized sensor geometry for an implantable glucose sensor |
US8423113B2 (en) | 2003-07-25 | 2013-04-16 | Dexcom, Inc. | Systems and methods for processing sensor data |
JP4708342B2 (en) | 2003-07-25 | 2011-06-22 | デックスコム・インコーポレーテッド | Oxygen augmentation membrane system for use in implantable devices |
US8060173B2 (en) | 2003-08-01 | 2011-11-15 | Dexcom, Inc. | System and methods for processing analyte sensor data |
US8369919B2 (en) | 2003-08-01 | 2013-02-05 | Dexcom, Inc. | Systems and methods for processing sensor data |
US8622905B2 (en) | 2003-08-01 | 2014-01-07 | Dexcom, Inc. | System and methods for processing analyte sensor data |
US8886273B2 (en) | 2003-08-01 | 2014-11-11 | Dexcom, Inc. | Analyte sensor |
US7519408B2 (en) | 2003-11-19 | 2009-04-14 | Dexcom, Inc. | Integrated receiver for continuous analyte sensor |
US20080119703A1 (en) | 2006-10-04 | 2008-05-22 | Mark Brister | Analyte sensor |
US20190357827A1 (en) | 2003-08-01 | 2019-11-28 | Dexcom, Inc. | Analyte sensor |
US8761856B2 (en) | 2003-08-01 | 2014-06-24 | Dexcom, Inc. | System and methods for processing analyte sensor data |
US7591801B2 (en) | 2004-02-26 | 2009-09-22 | Dexcom, Inc. | Integrated delivery device for continuous glucose sensor |
US7774145B2 (en) | 2003-08-01 | 2010-08-10 | Dexcom, Inc. | Transcutaneous analyte sensor |
US20140121989A1 (en) | 2003-08-22 | 2014-05-01 | Dexcom, Inc. | Systems and methods for processing analyte sensor data |
US7920906B2 (en) | 2005-03-10 | 2011-04-05 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US8233959B2 (en) | 2003-08-22 | 2012-07-31 | Dexcom, Inc. | Systems and methods for processing analyte sensor data |
US9247900B2 (en) | 2004-07-13 | 2016-02-02 | Dexcom, Inc. | Analyte sensor |
US8615282B2 (en) | 2004-07-13 | 2013-12-24 | Dexcom, Inc. | Analyte sensor |
US8287453B2 (en) | 2003-12-05 | 2012-10-16 | Dexcom, Inc. | Analyte sensor |
US8423114B2 (en) | 2006-10-04 | 2013-04-16 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
EP1711790B1 (en) | 2003-12-05 | 2010-09-08 | DexCom, Inc. | Calibration techniques for a continuous analyte sensor |
US8364231B2 (en) | 2006-10-04 | 2013-01-29 | Dexcom, Inc. | Analyte sensor |
US11633133B2 (en) | 2003-12-05 | 2023-04-25 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
EP2316331B1 (en) | 2003-12-09 | 2016-06-29 | Dexcom, Inc. | Signal processing for continuous analyte sensor |
US8808228B2 (en) | 2004-02-26 | 2014-08-19 | Dexcom, Inc. | Integrated medicament delivery device for use with continuous analyte sensor |
US8277713B2 (en) | 2004-05-03 | 2012-10-02 | Dexcom, Inc. | Implantable analyte sensor |
US8792955B2 (en) | 2004-05-03 | 2014-07-29 | Dexcom, Inc. | Transcutaneous analyte sensor |
US8565848B2 (en) | 2004-07-13 | 2013-10-22 | Dexcom, Inc. | Transcutaneous analyte sensor |
WO2006127694A2 (en) | 2004-07-13 | 2006-11-30 | Dexcom, Inc. | Analyte sensor |
US7654956B2 (en) | 2004-07-13 | 2010-02-02 | Dexcom, Inc. | Transcutaneous analyte sensor |
US20060016700A1 (en) | 2004-07-13 | 2006-01-26 | Dexcom, Inc. | Transcutaneous analyte sensor |
US7783333B2 (en) | 2004-07-13 | 2010-08-24 | Dexcom, Inc. | Transcutaneous medical device with variable stiffness |
US8133178B2 (en) | 2006-02-22 | 2012-03-13 | Dexcom, Inc. | Analyte sensor |
US8744546B2 (en) | 2005-05-05 | 2014-06-03 | Dexcom, Inc. | Cellulosic-based resistance domain for an analyte sensor |
US8060174B2 (en) | 2005-04-15 | 2011-11-15 | Dexcom, Inc. | Analyte sensing biointerface |
US9757061B2 (en) | 2006-01-17 | 2017-09-12 | Dexcom, Inc. | Low oxygen in vivo analyte sensor |
US7831287B2 (en) | 2006-10-04 | 2010-11-09 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
JP2010517693A (en) | 2007-02-06 | 2010-05-27 | グルメトリクス, インコーポレイテッド | Optical system and method for ratiometric measurement of blood glucose concentration |
US7751863B2 (en) | 2007-02-06 | 2010-07-06 | Glumetrics, Inc. | Optical determination of ph and glucose |
JP5517919B2 (en) | 2007-05-10 | 2014-06-11 | グルメトリクス、 インク. | Balanced non-consumable fluorescent sensor for immediate intravascular glucose measurement |
JP2010527010A (en) * | 2007-05-10 | 2010-08-05 | グルメトリクス、 インク. | Apparatus and method for calibrating an analyte sensor |
US20080306434A1 (en) | 2007-06-08 | 2008-12-11 | Dexcom, Inc. | Integrated medicament delivery device for use with continuous analyte sensor |
US9452258B2 (en) | 2007-10-09 | 2016-09-27 | Dexcom, Inc. | Integrated insulin delivery system with continuous glucose sensor |
US8417312B2 (en) | 2007-10-25 | 2013-04-09 | Dexcom, Inc. | Systems and methods for processing sensor data |
JP5631215B2 (en) | 2007-11-21 | 2014-11-26 | メドトロニック ミニメド インコーポレイテッド | Blood sugar management maintenance system |
US8682408B2 (en) | 2008-03-28 | 2014-03-25 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
US11730407B2 (en) | 2008-03-28 | 2023-08-22 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
US8583204B2 (en) | 2008-03-28 | 2013-11-12 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
WO2009129186A2 (en) * | 2008-04-17 | 2009-10-22 | Glumetrics, Inc. | Sensor for percutaneous intravascular deployment without an indwelling cannula |
WO2010033724A2 (en) | 2008-09-19 | 2010-03-25 | Dexcom, Inc. | Particle-containing membrane and particulate electrode for analyte sensors |
EP2410910A4 (en) | 2009-03-27 | 2014-10-15 | Dexcom Inc | Methods and systems for promoting glucose management |
US9517023B2 (en) | 2009-06-01 | 2016-12-13 | Profusa, Inc. | Method and system for directing a localized biological response to an implant |
US20110077477A1 (en) | 2009-09-30 | 2011-03-31 | Glumetrics, Inc. | Sensors with thromboresistant coating |
US8467843B2 (en) * | 2009-11-04 | 2013-06-18 | Glumetrics, Inc. | Optical sensor configuration for ratiometric correction of blood glucose measurement |
WO2011075711A1 (en) * | 2009-12-17 | 2011-06-23 | Glumetrics, Inc. | System and method for maintaining glycemic control based on glucose activity measurements |
US8473222B2 (en) * | 2010-03-11 | 2013-06-25 | Glumetrics, Inc. | Measurement devices and methods for measuring analyte concentration incorporating temperature and pH correction |
US10010272B2 (en) | 2010-05-27 | 2018-07-03 | Profusa, Inc. | Tissue-integrating electronic apparatus |
US20110319738A1 (en) * | 2010-06-29 | 2011-12-29 | Abbott Diabetes Care Inc. | Medical Devices and Insertion Systems and Methods |
KR101690535B1 (en) | 2010-10-06 | 2017-01-09 | 프로퓨사 인코퍼레이티드 | Tissue-integrating sensors |
WO2012056363A1 (en) * | 2010-10-27 | 2012-05-03 | Koninklijke Philips Electronics N.V. | Splittable needle with fiber probe |
ES2847578T3 (en) | 2011-04-15 | 2021-08-03 | Dexcom Inc | Advanced analyte sensor calibration and error detection |
US8734345B2 (en) | 2011-08-01 | 2014-05-27 | Covidien Lp | Real time intravascular monitoring device |
WO2014074621A1 (en) * | 2012-11-07 | 2014-05-15 | Glumetrics, Inc. | Dry insertion and one-point in vivo calibration of an optical analyte sensor |
EP2859911A1 (en) | 2013-10-11 | 2015-04-15 | qSTAR Medical SAS | Vascular access port devices with incorporated sensors |
US10251605B2 (en) | 2015-02-16 | 2019-04-09 | Verily Life Sciences Llc | Bandage type of continuous glucose monitoring system |
US10201295B2 (en) | 2015-03-13 | 2019-02-12 | Verily Life Sciences Llc | User interactions for a bandage type monitoring device |
US10292630B2 (en) | 2015-06-01 | 2019-05-21 | Verily Life Sciences Llc | Optical sensor for bandage type monitoring device |
US10765353B2 (en) | 2015-07-02 | 2020-09-08 | Verily Life Sciences Llc | Calibration methods for a bandage-type analyte sensor |
USD806493S1 (en) | 2015-07-22 | 2018-01-02 | Tti (Macao Commercial Offshore) Limited | Tool adapter |
USD780548S1 (en) | 2015-07-22 | 2017-03-07 | Ac (Macao Commercial Offshore) Limited | Power tool |
US10105100B2 (en) | 2015-07-28 | 2018-10-23 | Verily Life Sciences Llc | Display on a bandage-type monitoring device |
WO2017165298A1 (en) * | 2016-03-22 | 2017-09-28 | Government Of The United States, As Represented By The Secretary Of The Air Force | Vascular access disassembling needle device and method |
WO2018119400A1 (en) | 2016-12-22 | 2018-06-28 | Profusa, Inc. | System and single-channel luminescent sensor for and method of determining analyte value |
EP4230158A1 (en) * | 2022-02-22 | 2023-08-23 | BIOTRONIK SE & Co. KG | Introducer tool |
Citations (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4345606A (en) * | 1977-12-13 | 1982-08-24 | Littleford Philip O | Split sleeve introducers for pacemaker electrodes and the like |
US4654031A (en) * | 1985-04-15 | 1987-03-31 | Warner-Lambert Company | Flash chamber |
US4821738A (en) * | 1987-11-19 | 1989-04-18 | Marquest Medical Products, Inc. | Arterial blood gas syringe |
US4919767A (en) * | 1987-08-04 | 1990-04-24 | Imperial Chemical Industries Plc | Sensor and method for analyte determination |
US5005576A (en) * | 1988-04-09 | 1991-04-09 | Hewlett-Packard Company | Optical probe |
US5141497A (en) * | 1989-06-06 | 1992-08-25 | Becton, Dickinson And Company | Apparatus and method for an introducer |
US5143066A (en) * | 1990-05-08 | 1992-09-01 | University Of Pittsburgh | Optical fiber sensors for continuous monitoring of biochemicals and related method |
US5180376A (en) * | 1990-05-01 | 1993-01-19 | Cathco, Inc. | Non-buckling thin-walled sheath for the percutaneous insertion of intraluminal catheters |
US5334157A (en) * | 1993-09-09 | 1994-08-02 | Gesco International, Inc. | Catheter introducer |
US5409469A (en) * | 1993-11-04 | 1995-04-25 | Medtronic, Inc. | Introducer system having kink resistant splittable sheath |
US6156010A (en) * | 1997-06-17 | 2000-12-05 | Injectimed, Inc. | Method and apparatus for introducing an intravenous catheter |
US6254586B1 (en) * | 1998-09-25 | 2001-07-03 | Minimed Inc. | Method and kit for supplying a fluid to a subcutaneous placement site |
US6273874B1 (en) * | 1999-08-18 | 2001-08-14 | Becton, Dickinson And Company | Protected peelable U-wing introducer |
US6299583B1 (en) * | 1998-03-17 | 2001-10-09 | Cardiox Corporation | Monitoring total circulating blood volume and cardiac output |
US6366726B1 (en) * | 1995-11-20 | 2002-04-02 | Cirrex Corp. | Fiber optic probes for indwelling investigations |
US20020072661A1 (en) * | 2000-12-13 | 2002-06-13 | Wiesmann William P. | Minimally invasive system for assessment of organ function |
US6584335B1 (en) * | 1997-08-09 | 2003-06-24 | Roche Diagnostics Gmbh | Analytical device for in vivo analysis in the body of a patient |
US20030187589A1 (en) * | 2002-03-28 | 2003-10-02 | Kaoru Terashima | Humoral testing unit and a humoral testing apparatus |
US6663595B2 (en) * | 1999-12-23 | 2003-12-16 | Tfx Medical, Inc. | Peelable PTFE sheaths and methods for manufacture of same |
US20040006379A1 (en) * | 2000-10-06 | 2004-01-08 | Expanding Concepts, L.L.C. | Epidural thermal posterior annuloplasty |
US20040023317A1 (en) * | 2002-03-29 | 2004-02-05 | Board Of Regents Of The University Of Texas System | Implantable biosensor from stratified nanostructured membranes |
US20040111018A1 (en) * | 2002-12-09 | 2004-06-10 | Research and Education Institute | Conjunctival monitor |
US20040260162A1 (en) * | 2003-03-15 | 2004-12-23 | Daniel Rohleder | Analysis system for reagent-free determination of the concentration of an analyte in living tissue |
US20040267203A1 (en) * | 2003-06-26 | 2004-12-30 | Potter Daniel J. | Splittable cannula having radiopaque marker |
US20050054975A1 (en) * | 2002-09-24 | 2005-03-10 | Bhavesh Patel | Peripherally inserted central catheter with continuous central venous oximetry and proximal high flow port |
US20050113658A1 (en) * | 2003-11-26 | 2005-05-26 | Becton, Dickinson And Company | Fiber optic device for sensing analytes and method of making same |
US20050267326A1 (en) * | 2001-10-02 | 2005-12-01 | Alfred E. Mann Institute For Biomedical Eng. At The University Of Southern California | Percutaneous chemical sensor based on fluorescence resonant energy transfer (FRET) |
US20060079740A1 (en) * | 2000-05-15 | 2006-04-13 | Silver James H | Sensors for detecting substances indicative of stroke, ischemia, or myocardial infarction |
US20060083688A1 (en) * | 2000-12-05 | 2006-04-20 | Bakthan Singaram | Optical determination of glucose utilizing boronic acid adducts |
US20060189979A1 (en) * | 2005-02-23 | 2006-08-24 | Esch Brady D | Methods and apparatus for coagulating and/or constricting hollow anatomical structures |
WO2006117154A1 (en) * | 2005-05-03 | 2006-11-09 | Rheinisch-Westfälische Technische Hochschule Aachen | Device for detecting physiological measured variables within the body |
US20070081758A1 (en) * | 2005-09-29 | 2007-04-12 | Ichiro Tono | Optical waveguide type biochemical sensor chip and method of manufacturing the same |
US20070100356A1 (en) * | 1999-04-09 | 2007-05-03 | Evalve, Inc. | Delivery device, systems and methods of use |
US7229450B1 (en) * | 2003-02-11 | 2007-06-12 | Pacesetter, Inc. | Kink resistant introducer with mapping capabilities |
US20070244382A1 (en) * | 2005-11-15 | 2007-10-18 | Mark Ries Robinson | Blood Analyte Determinations |
US20080021294A1 (en) * | 2006-07-14 | 2008-01-24 | Levin Paul D | Disposable blood glucose sensor with internal pump |
US20080027245A1 (en) * | 2006-07-25 | 2008-01-31 | Glumetrics Inc. | Fluorescent dyes for use in glucose sensing |
US20080086042A1 (en) * | 2006-10-04 | 2008-04-10 | Dexcom, Inc. | Analyte sensor |
US20080212918A1 (en) * | 2007-03-02 | 2008-09-04 | Babin Steven M | Fiber Optic Sensor Device for Measuring Chromophoric Compounds in Biological Fluid |
US20090088615A1 (en) * | 2007-10-01 | 2009-04-02 | Mark Ries Robinson | Indwelling Fiber Optic Probe for Blood Glucose Measurements |
US20090196864A1 (en) * | 2005-10-20 | 2009-08-06 | Bulla Lee A | Insecticides that target protein kinase a (pka) |
US7879024B2 (en) * | 2003-06-26 | 2011-02-01 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Splittable cannula having radiopaque marker |
US7945312B2 (en) * | 2001-09-04 | 2011-05-17 | Bioluminate, Inc. | Multisensor probe for tissue identification |
US8512245B2 (en) * | 2008-04-17 | 2013-08-20 | Glumetrics, Inc. | Sensor for percutaneous intravascular deployment without an indwelling cannula |
Family Cites Families (285)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1120700A (en) | 1914-02-02 | 1914-12-15 | Hoechst Ag | Arseno-azo compounds and process of making same. |
US1334901A (en) * | 1918-12-10 | 1920-03-23 | Higdon Emma | Turning-sheet and pad |
US2112244A (en) * | 1933-08-26 | 1938-03-29 | Squibb & Sons Inc | Amino azobenzene arsonic acids |
US2274551A (en) * | 1939-06-30 | 1942-02-24 | Eastman Kodak Co | Derivatives of resins and their preparation |
US2496151A (en) * | 1946-08-14 | 1950-01-31 | Harvel Corp | Azo dyestuffs |
US3011293A (en) | 1953-03-24 | 1961-12-05 | Pickering Dorothy Frances | Collapsible container |
US2812524A (en) | 1955-03-25 | 1957-11-12 | Lawrence C Pruitt | Patient turner |
AT267017B (en) | 1965-04-02 | 1968-12-10 | Ceskoslovenska Akademie Ved | Process for the preparation of new, substituted 2,7-bisphenylazo derivatives of chromotropic acid |
US3302219A (en) * | 1966-01-14 | 1967-02-07 | Joe F Harris | Hospital bed and lifting and turning device |
US3488098A (en) * | 1968-03-26 | 1970-01-06 | Teletype Corp | Motion translating device |
US3659586A (en) | 1969-05-20 | 1972-05-02 | Univ Johns Hopkins | Percutaneous carbon dioxide sensor and process for measuring pulmonary efficiency |
CH530006A (en) * | 1970-10-01 | 1972-10-31 | Hoffmann La Roche | Electrode arrangement |
US3827089A (en) | 1971-09-16 | 1974-08-06 | W Grow | Turnover bed assembly |
US3808615A (en) * | 1972-05-22 | 1974-05-07 | W Geary | Bed and pillow assembly |
US3865548A (en) * | 1972-06-13 | 1975-02-11 | Einstein Coll Med | Analytical apparatus and process |
CH564771A5 (en) | 1973-05-10 | 1975-07-31 | Hoffmann La Roche | |
US3884225A (en) | 1973-06-01 | 1975-05-20 | Evelyn Ruth Witter | Bed patient turn and hold device |
SE428596B (en) | 1975-04-09 | 1983-07-11 | Raychem Corp | DEVICE FOR CONNECTING SUBSTRATE EXV RODS INCLUDING A MEMORIAL METAL BODY |
US3930580A (en) * | 1973-10-19 | 1976-01-06 | Medical Products Corporation | Sterilizable, peelable pouch or tray assembly |
US3909504A (en) | 1973-11-05 | 1975-09-30 | Carrier Tel Corp America Inc | Ruggedized package for electronic components and the like |
GB1447163A (en) | 1974-03-13 | 1976-08-25 | Gibbs J R | Beds |
US3895403A (en) | 1974-04-05 | 1975-07-22 | Sanford Davis | Patient orienting device |
US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
US4041932A (en) | 1975-02-06 | 1977-08-16 | Fostick Moshe A | Method for monitoring blood gas tension and pH from outside the body |
DE2508637C3 (en) * | 1975-02-28 | 1979-11-22 | Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen | Arrangement for the optical measurement of blood gases |
IT1057223B (en) | 1976-02-19 | 1982-03-10 | Cselt Centro Studi Lab Telecom | OPTICAL EQUALIZER FOR TRANSMISSION OF SIGNALS OF MULTIMODE OPTICAL GUIDES |
FR2350831A1 (en) | 1976-05-13 | 1977-12-09 | Caneva Moutinho Mario | Bedridden patient movement aid mechanism - has cloth harness with ends coupled to motor driven rope reeved round supports |
GB2005418B (en) * | 1977-07-26 | 1982-04-21 | Searle & Co | Electrochemical sensor system |
FR2403098A1 (en) | 1977-09-19 | 1979-04-13 | Merieux Inst | NEW MATERIAL CAPABLE OF REVERSIBLE BINDING OF BIOLOGICAL MACROMOLECULES, ITS PREPARATION AND APPLICATION |
CA1065969A (en) * | 1977-09-28 | 1979-11-06 | Gratien Bouillon | Self-blocking cerebral catheter |
US4200110A (en) * | 1977-11-28 | 1980-04-29 | United States Of America | Fiber optic pH probe |
NO141592C (en) | 1978-06-22 | 1980-04-23 | Kjell Roeisaeth | DEVICE FOR HANDLING A PERSON ON A SUBSTRATE |
US4269605A (en) | 1978-06-28 | 1981-05-26 | Amicon Corporation | Method and kit for separation of glycoproteins |
US4344438A (en) | 1978-08-02 | 1982-08-17 | The United States Of America As Represented By The Department Of Health, Education And Welfare | Optical sensor of plasma constituents |
US4180879A (en) * | 1978-08-04 | 1980-01-01 | Mann Rose A | Body positioner |
US4306562A (en) | 1978-12-01 | 1981-12-22 | Cook, Inc. | Tear apart cannula |
GB2038017B (en) | 1978-12-20 | 1982-11-24 | Standard Telephones Cables Ltd | Optical fibre directional coupler |
JPS5618342Y2 (en) | 1979-04-26 | 1981-04-30 | ||
US4307933A (en) | 1980-02-20 | 1981-12-29 | General Dynamics, Pomona Division | Optical fiber launch coupler |
US4358851A (en) | 1980-02-28 | 1982-11-09 | Xerox Corporation | Fiber optic laser device and light emitter utilizing the device |
DE3036868A1 (en) | 1980-09-30 | 1982-05-13 | Siemens AG, 1000 Berlin und 8000 München | Coupling, junction-forming and combining light conductor fibres - using supporting body with grooves for fixing fibres and grinding or polishing region of grooves |
US4371374A (en) * | 1980-11-17 | 1983-02-01 | The Rockefeller University | Monitoring metabolic control in diabetic patients by measuring glycosylated amino acids and peptides in urine |
EP0061884A1 (en) | 1981-03-30 | 1982-10-06 | Imperial Chemical Industries Plc | Optical fibre sensor |
US4659817A (en) * | 1981-05-01 | 1987-04-21 | The Children's Medical Center Corporation | Reporter compounds containing boron |
US4459712A (en) | 1981-06-11 | 1984-07-17 | Pathan Rajendra K | Hospital bed |
SE448059B (en) * | 1981-07-27 | 1987-01-19 | Torsten Persson | DEVICE FOR SIDING OF SINGLE PERSONS |
GB2103786A (en) | 1981-08-14 | 1983-02-23 | Ici Plc | Fibre optic sensor |
EP0073558A3 (en) | 1981-08-25 | 1984-09-26 | THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce | Fiber optic ph probe for tissue measurements |
US4476870A (en) | 1982-03-30 | 1984-10-16 | The United States Of America As Represented By The Department Of Health And Human Services | Fiber optic PO.sbsb.2 probe |
DE3216516A1 (en) | 1982-05-03 | 1983-11-03 | Siemens AG, 1000 Berlin und 8000 München | OPTICAL WAVELENGTH MULTIPLEXER IN ACCORDANCE WITH THE GRILLED PRINCIPLE |
USRE32514E (en) | 1982-06-14 | 1987-10-06 | Eastman Kodak Company | Polymer compositions having a low coefficient of friction |
US4515584A (en) * | 1982-07-06 | 1985-05-07 | Fujisawa Pharmaceutical Co., Ltd. | Artificial pancreas |
US4557900A (en) | 1982-09-28 | 1985-12-10 | Cardiovascular Devices, Inc. | Optical sensor with beads |
US4465335A (en) | 1982-10-12 | 1984-08-14 | The United States Of America As Represented By The Secretary Of The Army | Concentric core optical fiber coupler |
US4490867A (en) * | 1982-12-21 | 1985-01-01 | Lycksele Nya Platprodukter Ab | Bed rocking mechanism |
US5030420A (en) | 1982-12-23 | 1991-07-09 | University Of Virginia Alumni Patents Foundation | Apparatus for oxygen determination |
US4495293A (en) * | 1983-02-24 | 1985-01-22 | Abbott Laboratories | Fluorometric assay |
US4528616A (en) | 1983-03-28 | 1985-07-09 | Gte Automatic Electric Inc. | Printed wiring board enclosure |
US4548907A (en) | 1983-09-14 | 1985-10-22 | Allied Corporation | Fluorescent fluid determination method and apparatus |
US5007704A (en) * | 1983-10-28 | 1991-04-16 | Baxter International Inc. | Oximeter |
US4754538A (en) | 1983-11-15 | 1988-07-05 | Raychem Corporation | Annular tube-like driver |
AU559681B2 (en) | 1983-12-19 | 1987-03-19 | Litton Systems, Incorporated | Three port coupler |
SE441128B (en) * | 1984-01-25 | 1985-09-09 | Asea Ab | FIBER OPTICAL SENSOR FOR SURGERY OF DYNAMIC ACCELERATION |
JPS60231156A (en) * | 1984-04-30 | 1985-11-16 | Kuraray Co Ltd | Liquid junction type reference electrode |
US4846543A (en) | 1984-05-02 | 1989-07-11 | Kaptron, Inc. | Star coupler for optical fibers |
US5217691A (en) | 1984-11-19 | 1993-06-08 | Miles Inc. | Nonenzymatic glucose test |
US4621049A (en) | 1984-11-19 | 1986-11-04 | Miles Laboratories, Inc. | Enzymatic high range glucose test |
US4803049A (en) * | 1984-12-12 | 1989-02-07 | The Regents Of The University Of California | pH-sensitive optrode |
DE3446726A1 (en) | 1984-12-21 | 1986-06-26 | Fa. Carl Zeiss, 7920 Heidenheim | OPTICAL ARRANGEMENT WITH A CONCAVE MIRROR OR CONCAVE GRID |
GB8504521D0 (en) * | 1985-02-21 | 1985-03-27 | Genetics Int Inc | Electrochemical assay |
DE3509262A1 (en) | 1985-03-12 | 1985-10-10 | Heinrich Dipl.-Ing. 1000 Berlin Ranke | Bed for the disabled having a lifting device and a bath tub |
US4776047A (en) | 1985-05-07 | 1988-10-11 | Med Bed Technologies, Inc. | Multiple function invalid bed arrangement |
US4750795A (en) | 1985-06-13 | 1988-06-14 | The Board Of Trustees Of The Leland Stanford Junior University | Optical fiber coupler |
US4943364A (en) | 1985-06-21 | 1990-07-24 | Spectramed, Inc. | Fiber optic CO2 sensor |
US4796633A (en) * | 1985-06-25 | 1989-01-10 | American Hospital Supply Corporation | Method and apparatus for in vitro calibration of oxygen saturation monitor |
US4650472A (en) * | 1985-08-30 | 1987-03-17 | Cook, Incorporated | Apparatus and method for effecting percutaneous catheterization of a blood vessel using a small gauge introducer needle |
US4629451A (en) | 1985-09-23 | 1986-12-16 | Victory Engineering Corp. | Stereotaxic array plug |
FR2588471B1 (en) | 1985-10-15 | 1990-06-08 | Bernard Jean Marc | ANTI-PRESSURE BED |
CN1003110B (en) | 1985-11-15 | 1989-01-25 | 李鸿柱 | Program-controlled rejuvenating bed |
JPH025799Y2 (en) * | 1986-02-07 | 1990-02-13 | ||
US4684538A (en) | 1986-02-21 | 1987-08-04 | Loctite Corporation | Polysiloxane urethane compounds and adhesive compositions, and method of making and using the same |
US4710623A (en) | 1986-02-27 | 1987-12-01 | Eli Lilly And Company | Optical fiber catheter with fiber-contained reactive element |
US4675925A (en) | 1986-04-03 | 1987-06-30 | Henrietta Littleton | Device for manipulating bedridden patients |
US4798738A (en) | 1986-10-10 | 1989-01-17 | Cardiovascular Devices, Inc. | Micro sensor |
US4801187A (en) * | 1986-04-30 | 1989-01-31 | Baxter Travenol Laboratories, Inc. | Liquid light tube end cap assembly |
US4703756A (en) | 1986-05-06 | 1987-11-03 | The Regents Of The University Of California | Complete glucose monitoring system with an implantable, telemetered sensor module |
US4822127A (en) * | 1986-06-16 | 1989-04-18 | Shiley Incorporated | Multi-channel optical transmission system |
US4927222A (en) | 1986-06-16 | 1990-05-22 | Shiley Incorporated | Dual optical fiber device |
US4854321A (en) | 1986-06-18 | 1989-08-08 | Medex, Inc. | Integrated optic system for monitoring blood gases |
US4727730A (en) * | 1986-07-10 | 1988-03-01 | Medex, Inc. | Integrated optic system for monitoring blood pressure |
US4886338A (en) | 1986-10-10 | 1989-12-12 | Minnesota Mining And Manufacturing Company | Optical fiber event sensor |
US5012809A (en) | 1986-10-10 | 1991-05-07 | Shulze John E | Fiber optic catheter system with fluorometric sensor and integral flexure compensation |
US4794619A (en) | 1986-12-05 | 1988-12-27 | Conax Buffalo Corporation | Optical fiber temperature sensor |
US5162130A (en) | 1986-12-17 | 1992-11-10 | Mclaughlin Gerald G | Light activated coloration of dental restorations |
US4833091A (en) | 1987-02-06 | 1989-05-23 | Shiley Incorporated | Sensor system |
US5093266A (en) * | 1987-02-06 | 1992-03-03 | Shiley Inc. | Sensor system |
US4746751A (en) | 1987-05-07 | 1988-05-24 | Baxter Travenol Laboratories, Inc. | Silicone reactive/fluorescent silane dye compositions |
DE3720736A1 (en) | 1987-06-23 | 1989-01-05 | Erwin Dr Schleicher | Method, reagents and equipment for the simple determination of non-enzymatically glycosylated proteins in body fluids |
US4816130A (en) * | 1987-07-02 | 1989-03-28 | Becton, Dickinson And Company | Blood electrolyte sensors including crosslinked polyetherurethane membranes |
DE3869237D1 (en) | 1987-07-07 | 1992-04-23 | Siemens Ag | SENSOR FOR GASES OR IONS. |
US4861728A (en) | 1987-07-24 | 1989-08-29 | Becton, Dickinson And Company | Immunoassay of glycosylated hemoglobin using a labeled boron reagent |
US4785814A (en) | 1987-08-11 | 1988-11-22 | Cordis Corporation | Optical probe for measuring pH and oxygen in blood and employing a composite membrane |
US4851195A (en) | 1987-08-17 | 1989-07-25 | Pfizer Hospital Products Group, Inc. | Carbon dioxide sensor |
US4923273A (en) | 1987-10-13 | 1990-05-08 | Texas A&M University System | Method for producing reflective taps in optical fibers and applications thereof |
US5185263A (en) * | 1987-10-23 | 1993-02-09 | Avl Medical Instruments Ag | Method for calibration of a measurement apparatus |
FR2624007A1 (en) | 1987-12-02 | 1989-06-09 | Perdu Jean Francois | Sanitary bed with special rollers for treatment of bedridden patients |
US4906232A (en) * | 1988-03-01 | 1990-03-06 | Abbott Laboratories | Intravascular delivery device |
US4838269A (en) | 1988-03-24 | 1989-06-13 | Scimed Life Systems, Inc. | Manifold for angioplasty balloon catheter |
US4960412A (en) | 1988-04-15 | 1990-10-02 | Universal Medical Instrument Corp. | Catheter introducing system |
US4903707A (en) * | 1988-04-22 | 1990-02-27 | Camino Laboratories | Ventricular catheter assembly |
US4872226A (en) | 1988-06-06 | 1989-10-10 | Robert Lonardo | Means for positioning bedfast patients |
US5361758A (en) | 1988-06-09 | 1994-11-08 | Cme Telemetrix Inc. | Method and device for measuring concentration levels of blood constituents non-invasively |
US5000901A (en) * | 1988-07-25 | 1991-03-19 | Abbott Laboratories | Fiber-optic physiological probes |
US4941308A (en) | 1988-07-25 | 1990-07-17 | Abbott Laboratories | Method of packaging for a sterilizable calibratable medical device |
AT390517B (en) | 1988-08-04 | 1990-05-25 | Avl Verbrennungskraft Messtech | OPTICAL SENSOR AND METHOD FOR THE PRODUCTION THEREOF |
US4966597A (en) | 1988-11-04 | 1990-10-30 | Cosman Eric R | Thermometric cardiac tissue ablation electrode with ultra-sensitive temperature detection |
US4937901A (en) | 1988-11-04 | 1990-07-03 | Brennan Louis G | Apparatus for turning a patient from a supine to a prone position and vice-versa |
US4985022A (en) | 1988-11-23 | 1991-01-15 | Med Institute, Inc. | Catheter having durable and flexible segments |
US4889407A (en) | 1988-12-02 | 1989-12-26 | Biomedical Sensors Limited | Optical waveguide sensor and method of making same |
US4939801A (en) | 1988-12-22 | 1990-07-10 | Schaal Gary A | Patient transporting and turning gurney |
IT1225494B (en) | 1988-12-23 | 1990-11-20 | Italpres Snc Di Fregni & C | APPARATUS TO PREVENT TRAINING AND TAKE CARE OF PADS IN LONG PATIENTS |
US5153827A (en) | 1989-01-30 | 1992-10-06 | Omni-Flow, Inc. | An infusion management and pumping system having an alarm handling system |
US5047208A (en) | 1989-02-23 | 1991-09-10 | Medtronic, Inc. | Blood gas monitoring sensors |
US4955862A (en) | 1989-05-22 | 1990-09-11 | Target Therapeutics, Inc. | Catheter and catheter/guide wire device |
US5182353A (en) * | 1989-08-16 | 1993-01-26 | Puritan-Bennett Corporation | Method for bonding an analyte-sensitive dye compound to an addition-cure silicone |
US5129906A (en) | 1989-09-08 | 1992-07-14 | Linvatec Corporation | Bioabsorbable tack for joining bodily tissue and in vivo method and apparatus for deploying same |
US5512246A (en) * | 1989-09-21 | 1996-04-30 | Anthony P. Russell | Method and means for detecting polyhydroxyl compounds |
US5137833A (en) | 1989-09-21 | 1992-08-11 | Russell Anthony P | Method for detecting polyhydroxyl compounds |
EP0428990B1 (en) | 1989-11-16 | 1995-02-15 | N.E. Chemcat Corporation | Method and apparatus for liquid coating for honeycomb structure |
US4946038A (en) | 1989-12-20 | 1990-08-07 | Rolland Eaton | Medicine container and cover therefor |
US5054497A (en) | 1990-02-21 | 1991-10-08 | Biomedical Monitors And Implants, Inc. | Cranial sensor attaching device and method for its use |
US5098618A (en) * | 1990-03-14 | 1992-03-24 | Joseph Zelez | Surface modification of plastic substrates |
EP0447196A1 (en) * | 1990-03-16 | 1991-09-18 | Hewlett-Packard Company | Boronic acid dyes |
US5175016A (en) | 1990-03-20 | 1992-12-29 | Minnesota Mining And Manufacturing Company | Method for making gas sensing element |
US5104388A (en) * | 1990-05-08 | 1992-04-14 | Fbk International Corporation | Membrane splittable tubing |
US5047627A (en) | 1990-05-18 | 1991-09-10 | Abbott Laboratories | Configuration fiber-optic blood gas sensor bundle and method of making |
US5109452A (en) * | 1990-07-16 | 1992-04-28 | Puritan-Bennett Corporation | Electrical-optical hybrid connector |
US5279596A (en) * | 1990-07-27 | 1994-01-18 | Cordis Corporation | Intravascular catheter with kink resistant tip |
US5166990A (en) | 1990-08-10 | 1992-11-24 | Puritan-Bennett Corporation | Multiple optical fiber event sensor and method of manufacture |
US5176882A (en) * | 1990-12-06 | 1993-01-05 | Hewlett-Packard Company | Dual fiberoptic cell for multiple serum measurements |
US5178267A (en) * | 1990-12-20 | 1993-01-12 | Abbott Laboratories | Packaging system for a sterilizable calbratable medical device |
US5082112A (en) * | 1991-02-05 | 1992-01-21 | United States Surgical Corporation | Package for endoscopic ligating instrument |
AR245376A1 (en) | 1991-02-25 | 1994-01-31 | Liliana Rosa Grinfeld Y Robert | Arterial profusion nozzle, for extra-corporal circulation and other uses. |
US5167715A (en) | 1991-03-04 | 1992-12-01 | General Electric Company | Apparatus and method for impregnating superconductor windings |
US5119463A (en) | 1991-04-09 | 1992-06-02 | Abbott Laboratories | Compound optical probe employing single optical waveguide |
JP2948678B2 (en) * | 1991-04-24 | 1999-09-13 | 玄々化学工業株式会社 | Vacuum coating equipment |
US5068931A (en) | 1991-06-21 | 1991-12-03 | Smith Gene A | Apparatus for lifting and turning a patient confined to a bed |
US5380304A (en) | 1991-08-07 | 1995-01-10 | Cook Incorporated | Flexible, kink-resistant, introducer sheath and method of manufacture |
US5305740A (en) * | 1991-09-12 | 1994-04-26 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Sealing means for endotracheal tubes |
US5261887A (en) | 1992-01-22 | 1993-11-16 | Baxter International Inc. | Easy-to-handle, self-guiding catheter stripper |
US5284153A (en) * | 1992-04-14 | 1994-02-08 | Brigham And Women's Hospital | Method for locating a nerve and for protecting nerves from injury during surgery |
US5168587A (en) | 1992-05-18 | 1992-12-08 | Shutes Robert S | Patient positioning device |
US5246109A (en) | 1992-05-22 | 1993-09-21 | Biomedical Sensors, Ltd. | Package for an active medical device |
US5230031A (en) | 1992-05-22 | 1993-07-20 | Biomedical Sensors, Ltd. | Barrier for a connector |
US5354448A (en) | 1992-05-22 | 1994-10-11 | Biomedical Sensors Ltd. | Electrochemical sensor |
US5280130A (en) * | 1992-05-22 | 1994-01-18 | Biomedical Sensors, Ltd. | Assembly of a tube and a part and apparatus and method of manufacture |
US5262037A (en) | 1992-05-22 | 1993-11-16 | Biomedical Sensors, Ltd. | Electrochemical sensor |
US5257338A (en) | 1992-05-22 | 1993-10-26 | Biomedical Sensors, Ltd. | Device for transmitting and returning light and apparatus and method of manufacture |
US5302731A (en) * | 1992-07-13 | 1994-04-12 | Becton, Dickinson And Company | Fluorescent pH indicators |
JP2599994Y2 (en) * | 1992-07-30 | 1999-09-27 | 株式会社堀場製作所 | Automatic calibration system for laboratory ion concentration meter |
US5290266A (en) * | 1992-08-14 | 1994-03-01 | General Electric Company | Flexible coating for magnetic resonance imaging compatible invasive devices |
JPH08501392A (en) | 1992-09-14 | 1996-02-13 | パーデュー リサーチ ファウンデーション | Chemical analysis by electrophoresis |
EP0596700A1 (en) | 1992-11-03 | 1994-05-11 | Hewlett-Packard Company | Cis-diol detection method and solid supports |
US5280548A (en) * | 1993-03-11 | 1994-01-18 | Boc Health Care, Inc. | Emission based fiber optic sensors for pH and carbon dioxide analysis |
CA2166201A1 (en) * | 1993-06-30 | 1995-01-12 | Barry Colin Crane | Biphasic material |
US5527325A (en) | 1993-07-09 | 1996-06-18 | Device For Vascular Intervention, Inc. | Atherectomy catheter and method |
US5954651A (en) | 1993-08-18 | 1999-09-21 | Scimed Life Systems, Inc. | Catheter having a high tensile strength braid wire constraint |
GB2284809B (en) * | 1993-11-07 | 1998-04-29 | Japan Res Dev Corp | A fluorescent phenylboronic acid suitable for use in the detection of saccharides |
US5511547A (en) * | 1994-02-16 | 1996-04-30 | Biomedical Sensors, Ltd. | Solid state sensors |
US5569186A (en) | 1994-04-25 | 1996-10-29 | Minimed Inc. | Closed loop infusion pump system with removable glucose sensor |
US5389217A (en) * | 1994-04-28 | 1995-02-14 | Biomedical Sensors Ltd. | Measurement of bladder oxygen |
ATE176048T1 (en) | 1994-05-02 | 1999-02-15 | Novartis Ag | OPTICAL SENSOR SYSTEM FOR DETERMINING PH VALUES AND IONIC STRENGTH |
US5658264A (en) | 1994-11-10 | 1997-08-19 | Target Therapeutics, Inc. | High performance spiral-wound catheter |
DE19502183C1 (en) | 1995-01-25 | 1996-08-14 | Wolfgang Dr Fleckenstein | Bracket for brain probes |
JP2799837B2 (en) | 1995-03-03 | 1998-09-21 | 科学技術振興事業団 | Boronic acid compounds having a binaphthyl group |
US5676784A (en) | 1995-03-15 | 1997-10-14 | Abbott Laboratories | Method of fabricating a heater coil for a catheter used to monitor cardiac output |
US5702373A (en) | 1995-08-31 | 1997-12-30 | Target Therapeutics, Inc. | Composite super-elastic alloy braid reinforced catheter |
US5634911A (en) | 1995-05-19 | 1997-06-03 | General Surgical Innovations, Inc. | Screw-type skin seal with inflatable membrane |
US5622259A (en) | 1995-06-07 | 1997-04-22 | Church; Jonathan M. | Reduction of discoloration in plastic materials |
US5545179A (en) | 1995-07-21 | 1996-08-13 | Ethicon Endo-Surgery, Inc. | Endoscopic access assembly |
JP3183390B2 (en) * | 1995-09-05 | 2001-07-09 | キヤノン株式会社 | Photoelectric conversion device and imaging device using the same |
US6019736A (en) * | 1995-11-06 | 2000-02-01 | Francisco J. Avellanet | Guidewire for catheter |
US6766183B2 (en) | 1995-11-22 | 2004-07-20 | Medtronic Minimed, Inc. | Long wave fluorophore sensor compounds and other fluorescent sensor compounds in polymers |
WO1997019188A1 (en) * | 1995-11-22 | 1997-05-29 | Minimed, Inc. | Detection of biological molecules using chemical amplification and optical sensors |
US6002954A (en) | 1995-11-22 | 1999-12-14 | The Regents Of The University Of California | Detection of biological molecules using boronate-based chemical amplification and optical sensors |
US5797876A (en) | 1995-11-27 | 1998-08-25 | Therox, Inc. | High pressure perfusion device |
US5951929A (en) | 1995-12-12 | 1999-09-14 | Medi-Dyne Inc. | Method for forming a catheter having overlapping welds |
USD388418S (en) | 1996-03-18 | 1997-12-30 | Iomega Corporation | Computer screen with an icon |
US5827242A (en) | 1996-06-21 | 1998-10-27 | Medtronic, Inc. | Reinforced catheter body and method for its fabrication |
US5755704A (en) | 1996-10-29 | 1998-05-26 | Medtronic, Inc. | Thinwall guide catheter |
US5747666A (en) | 1997-03-26 | 1998-05-05 | Willis; John P. | Point-of-care analyzer module |
US5947940A (en) | 1997-06-23 | 1999-09-07 | Beisel; Robert F. | Catheter reinforced to prevent luminal collapse and tensile failure thereof |
DE19738942A1 (en) * | 1997-09-05 | 1999-03-25 | Pulsion Verwaltungs Gmbh & Co | Method and device for determining the injection time and duration of injection in thermodilution measurements |
US5891114A (en) | 1997-09-30 | 1999-04-06 | Target Therapeutics, Inc. | Soft-tip high performance braided catheter |
WO1999024097A1 (en) | 1997-11-12 | 1999-05-20 | Stereotaxis, Inc. | Intracranial bolt and method of placing and using an intracranial bolt to position a medical device |
US8974386B2 (en) | 1998-04-30 | 2015-03-10 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US6175752B1 (en) * | 1998-04-30 | 2001-01-16 | Therasense, Inc. | Analyte monitoring device and methods of use |
DE19820808C2 (en) | 1998-05-09 | 2000-11-02 | Wolfgang Fleckenstein | Insertion device for brain probes |
US6702972B1 (en) * | 1998-06-09 | 2004-03-09 | Diametrics Medical Limited | Method of making a kink-resistant catheter |
EP1102560A4 (en) * | 1998-08-07 | 2003-03-12 | Infinite Biomedical Technologi | Implantable myocardial ischemia detection, indication and action technology |
US6304766B1 (en) | 1998-08-26 | 2001-10-16 | Sensors For Medicine And Science | Optical-based sensing devices, especially for in-situ sensing in humans |
PT1108207E (en) * | 1998-08-26 | 2008-08-06 | Sensors For Med & Science Inc | Optical-based sensing devices |
GB9821575D0 (en) | 1998-10-02 | 1998-11-25 | Diametrics Medical Limited | Cranial bolt |
GB2342863B (en) | 1998-10-02 | 2003-02-19 | Diametrics Medical Ltd | Probe |
DE29817986U1 (en) | 1998-10-08 | 1998-12-24 | Homedica Ag | Probe holder |
US6187130B1 (en) * | 1999-05-26 | 2001-02-13 | Scimed Life Systems, Inc. | Method of creating a tip on a catheter |
AU1429701A (en) | 1999-07-16 | 2001-02-05 | Board Of Regents, The University Of Texas System | General signaling protocols for chemical receptors in immobilized matrices |
US6682938B1 (en) * | 1999-09-15 | 2004-01-27 | The Regents Of The University Of California | Glucose sensing molecules having selected fluorescent properties |
US6464849B1 (en) | 1999-10-07 | 2002-10-15 | Pepex Biomedical, L.L.C. | Sensor for measuring a bioanalyte such as lactate |
US6363273B1 (en) * | 1999-12-22 | 2002-03-26 | Codman & Shurtleff, Inc. | Introducer element and method of using same |
US6375627B1 (en) | 2000-03-02 | 2002-04-23 | Agilent Technologies, Inc. | Physiological fluid extraction with rapid analysis |
US6361508B1 (en) * | 2000-04-20 | 2002-03-26 | The United States Of America As Represented By The Secretary Of The Army | Personal event monitor with linear omnidirectional response |
WO2001085256A2 (en) | 2000-05-05 | 2001-11-15 | Novo Nordisk A/S | Critical illness neuropathy |
US6442413B1 (en) | 2000-05-15 | 2002-08-27 | James H. Silver | Implantable sensor |
WO2001088534A2 (en) | 2000-05-16 | 2001-11-22 | Cygnus, Inc. | Methods for improving performance and reliability of biosensors |
EP1307464B1 (en) | 2000-08-04 | 2013-02-13 | Senseonics, Incorporated | Detection of analytes in aqueous environments |
US6387672B1 (en) | 2000-12-04 | 2002-05-14 | Beckman Coulter, Inc. | Photo-induced electron transfer fluorescent sensor molecules |
US6627177B2 (en) * | 2000-12-05 | 2003-09-30 | The Regents Of The University Of California | Polyhydroxyl-substituted organic molecule sensing optical in vivo method utilizing a boronic acid adduct and the device thereof |
US6653141B2 (en) | 2000-12-05 | 2003-11-25 | The Regents Of The University Of California | Polyhydroxyl-substituted organic molecule sensing method and device |
US6800451B2 (en) | 2001-01-05 | 2004-10-05 | Sensors For Medicine And Science, Inc. | Detection of glucose in solutions also containing an alpha-hydroxy acid or a beta-diketone |
US20070038155A1 (en) * | 2001-01-05 | 2007-02-15 | Kelly Paul B Jr | Attitude Indicator And Activity Monitoring Device |
CN100403978C (en) * | 2001-02-22 | 2008-07-23 | 花王株式会社 | Apparatus for measuring body fat |
US6544212B2 (en) | 2001-07-31 | 2003-04-08 | Roche Diagnostics Corporation | Diabetes management system |
US7349402B2 (en) * | 2002-03-25 | 2008-03-25 | Nokia Corporation | Communication system and method to be performed in a communication system |
US7226414B2 (en) | 2002-10-09 | 2007-06-05 | Biotex, Inc. | Method and apparatus for analyte sensing |
EP1571982A1 (en) * | 2002-11-27 | 2005-09-14 | Z-Tech (Canada) Inc. | Apparatus for determining adequacy of electrode-to-skin contact and electrode quality for bioelectrical measurements |
US7390462B2 (en) | 2002-12-17 | 2008-06-24 | The University Of Maryland Baltimore County | Ratiometric fluorescent pH sensor for non-invasive monitoring |
US6669929B1 (en) | 2002-12-30 | 2003-12-30 | Colgate Palmolive Company | Dentifrice containing functional film flakes |
US7216001B2 (en) * | 2003-01-22 | 2007-05-08 | Medtronic Xomed, Inc. | Apparatus for intraoperative neural monitoring |
EP1595149B1 (en) * | 2003-02-07 | 2007-06-20 | Koninklijke Philips Electronics N.V. | Device for determining a value that is representative of accelerations as well as an ergometer |
US7387611B2 (en) * | 2003-04-10 | 2008-06-17 | Matsushita Electric Industrial Co., Ltd. | Physical movement analyzer and physical movement analyzing method |
US7358094B2 (en) | 2003-05-01 | 2008-04-15 | Bell Michael L | Sensor system for saccharides |
US20080009687A1 (en) * | 2003-06-06 | 2008-01-10 | Smith Joseph T | Coiled circuit bio-sensor |
US7353055B2 (en) | 2003-06-18 | 2008-04-01 | Hogan Josh N | Non-invasive analysis system |
US8060173B2 (en) | 2003-08-01 | 2011-11-15 | Dexcom, Inc. | System and methods for processing analyte sensor data |
AU2003904336A0 (en) * | 2003-08-15 | 2003-08-28 | Medcare Systems Pty Ltd | An automated personal alarm monitor |
US7559894B2 (en) | 2003-09-18 | 2009-07-14 | New Paradigm Concepts, LLC | Multiparameter whole blood monitor and method |
US7181260B2 (en) * | 2003-11-14 | 2007-02-20 | Guillermo Gutierrez | Apparatus and method for measuring myocardial oxygen consumption |
US7499746B2 (en) * | 2004-01-30 | 2009-03-03 | Encore Medical Asset Corporation | Automated adaptive muscle stimulation method and apparatus |
GB2410793B (en) | 2004-02-05 | 2006-05-17 | Elan Vital | Fluid analyser systems |
US20050198837A1 (en) | 2004-03-11 | 2005-09-15 | Stephen Rawle | Shaving razors with multiple blades |
US7981058B2 (en) * | 2004-03-12 | 2011-07-19 | The Trustees Of Dartmouth College | Intelligent wearable monitor systems and methods |
WO2005119223A1 (en) | 2004-04-14 | 2005-12-15 | Bioprocessors Corp. | Compositions of matter useful as ph indicators and related methods |
US20050241959A1 (en) | 2004-04-30 | 2005-11-03 | Kenneth Ward | Chemical-sensing devices |
FI118951B (en) * | 2004-06-04 | 2008-05-30 | Newtest Oy | Sensor unit, device arrangement and method utilizing the device arrangement to form and display an assessment of bone mass development |
USD525632S1 (en) | 2004-07-12 | 2006-07-25 | Sevic System Ag | Set of icons for a portion of an automotive windshield display |
US20090171381A1 (en) * | 2007-12-28 | 2009-07-02 | Schmitz Gregory P | Devices, methods and systems for neural localization |
JP2006115948A (en) | 2004-10-19 | 2006-05-11 | Hitachi Ltd | Blood-sugar level measuring apparatus |
US20060105174A1 (en) | 2004-10-25 | 2006-05-18 | The Research Foundation Of State University Of New York | Optical pH sensor |
WO2006074337A1 (en) * | 2005-01-06 | 2006-07-13 | Lightouch Medical, Inc. | Specialized human servo device and process for tissue modulation of human fingertips |
US8060194B2 (en) | 2005-01-18 | 2011-11-15 | Braingate Co., Llc | Biological interface system with automated configuration |
US20060189926A1 (en) * | 2005-02-14 | 2006-08-24 | Hall W D | Apparatus and methods for analyzing body fluid samples |
USD559264S1 (en) * | 2005-11-10 | 2008-01-08 | Sony Corporation | Computer generated image for a display panel or screen |
USD550245S1 (en) | 2005-11-10 | 2007-09-04 | Sony Corporation | Computer generated image for a display panel or screen |
USD550242S1 (en) | 2005-11-10 | 2007-09-04 | Sony Corporation | Computer generated image for a display panel or screen |
DE102005056310B4 (en) | 2005-11-25 | 2017-02-02 | Drägerwerk AG & Co. KGaA | Method and device for monitoring infusions |
USD560950S1 (en) * | 2005-11-28 | 2008-02-05 | Bsh Bosch Und Siemens Hausgeraete Gmbh | Coffee machine |
USD544871S1 (en) | 2005-12-02 | 2007-06-19 | Samsung Electronics Co., Ltd. | Generated image for a portable telephone |
EP1813188B1 (en) | 2006-01-30 | 2011-03-30 | Pulsion Medical Systems AG | System for providing a dilution measuring point |
US20080154107A1 (en) | 2006-12-20 | 2008-06-26 | Jina Arvind N | Device, systems, methods and tools for continuous glucose monitoring |
EP2004054A2 (en) * | 2006-04-10 | 2008-12-24 | Arneborg Ernst | Portable balance function diagnostic system |
USD560224S1 (en) * | 2006-04-17 | 2008-01-22 | Samsung Electronics Co., Ltd. | Telephone with video display |
US20070265675A1 (en) * | 2006-05-09 | 2007-11-15 | Ams Research Corporation | Testing Efficacy of Therapeutic Mechanical or Electrical Nerve or Muscle Stimulation |
USD582427S1 (en) | 2006-10-12 | 2008-12-09 | Bystronic Laser Ag | Printed material and icon for computer display, electronic screen |
USD592223S1 (en) | 2006-10-12 | 2009-05-12 | Bystronic Laser Ag | Printed material and icon for computer display, electronic screen |
EP2087021B1 (en) | 2006-10-27 | 2011-12-28 | Basf Se | Radiation-curable mixture containing low-molecular, ethylenically unsaturated compounds having non-aromatic ring systems |
US8075499B2 (en) * | 2007-05-18 | 2011-12-13 | Vaidhi Nathan | Abnormal motion detector and monitor |
JP2010517693A (en) | 2007-02-06 | 2010-05-27 | グルメトリクス, インコーポレイテッド | Optical system and method for ratiometric measurement of blood glucose concentration |
US7751863B2 (en) | 2007-02-06 | 2010-07-06 | Glumetrics, Inc. | Optical determination of ph and glucose |
WO2008098011A1 (en) | 2007-02-06 | 2008-08-14 | Glumetrics, Inc. | Method for polymerizing a monomer solution within a cavity to generate a smooth polymer surface |
USD626143S1 (en) | 2007-02-06 | 2010-10-26 | Glumetrics, Inc. | Computer-generated icon for a blood glucose display |
US7829341B2 (en) * | 2007-07-11 | 2010-11-09 | Glumetrics, Inc. | Polyviologen boronic acid quenchers for use in analyte sensors |
DE602008006382D1 (en) | 2007-05-01 | 2011-06-01 | Glumetrics Inc | PYRIDINE-BORONIC ACID QUENCHER FOR USE IN ANALYTIC SENSORS |
JP5517919B2 (en) | 2007-05-10 | 2014-06-11 | グルメトリクス、 インク. | Balanced non-consumable fluorescent sensor for immediate intravascular glucose measurement |
JP2010527010A (en) | 2007-05-10 | 2010-08-05 | グルメトリクス、 インク. | Apparatus and method for calibrating an analyte sensor |
US8600681B2 (en) * | 2007-05-14 | 2013-12-03 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
USD580950S1 (en) | 2007-06-15 | 2008-11-18 | Microsoft Corporation | Icon for a portion of a display screen |
US7611012B2 (en) * | 2007-07-24 | 2009-11-03 | Michelle Ross | Insulin syringe storage rack |
WO2009021057A1 (en) * | 2007-08-06 | 2009-02-12 | Glumetrics, Inc. | Hpts-mono and bis cys-ma polymerizable fluorescent dyes for use in analyte sensors |
EP2194861A1 (en) * | 2007-09-06 | 2010-06-16 | Baxano, Inc. | Method, system and apparatus for neural localization |
WO2009036348A1 (en) * | 2007-09-14 | 2009-03-19 | Corventis, Inc. | Medical device automatic start-up upon contact to patient tissue |
JP5631215B2 (en) | 2007-11-21 | 2014-11-26 | メドトロニック ミニメド インコーポレイテッド | Blood sugar management maintenance system |
US20090275815A1 (en) | 2008-03-21 | 2009-11-05 | Nova Biomedical Corporation | Temperature-compensated in-vivo sensor |
USD610065S1 (en) * | 2008-12-19 | 2010-02-16 | Dr. Ing. H.C. F. Porsche Aktiengesellschaft | Automobile wheel |
US8376968B2 (en) * | 2009-05-15 | 2013-02-19 | The Hong Kong Polytechnic University | Method and system for quantifying an intention of movement of a user |
-
2009
- 2009-04-13 WO PCT/US2009/040379 patent/WO2009129186A2/en active Application Filing
- 2009-04-16 US US12/424,902 patent/US8512245B2/en active Active
-
2013
- 2013-08-19 US US13/970,469 patent/US20140058223A1/en not_active Abandoned
Patent Citations (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4345606A (en) * | 1977-12-13 | 1982-08-24 | Littleford Philip O | Split sleeve introducers for pacemaker electrodes and the like |
US4654031A (en) * | 1985-04-15 | 1987-03-31 | Warner-Lambert Company | Flash chamber |
US4919767A (en) * | 1987-08-04 | 1990-04-24 | Imperial Chemical Industries Plc | Sensor and method for analyte determination |
US4821738A (en) * | 1987-11-19 | 1989-04-18 | Marquest Medical Products, Inc. | Arterial blood gas syringe |
US5005576A (en) * | 1988-04-09 | 1991-04-09 | Hewlett-Packard Company | Optical probe |
US5141497A (en) * | 1989-06-06 | 1992-08-25 | Becton, Dickinson And Company | Apparatus and method for an introducer |
US5180376A (en) * | 1990-05-01 | 1993-01-19 | Cathco, Inc. | Non-buckling thin-walled sheath for the percutaneous insertion of intraluminal catheters |
US5143066A (en) * | 1990-05-08 | 1992-09-01 | University Of Pittsburgh | Optical fiber sensors for continuous monitoring of biochemicals and related method |
US5334157A (en) * | 1993-09-09 | 1994-08-02 | Gesco International, Inc. | Catheter introducer |
US5409469A (en) * | 1993-11-04 | 1995-04-25 | Medtronic, Inc. | Introducer system having kink resistant splittable sheath |
US6366726B1 (en) * | 1995-11-20 | 2002-04-02 | Cirrex Corp. | Fiber optic probes for indwelling investigations |
US6370406B1 (en) * | 1995-11-20 | 2002-04-09 | Cirrex Corp. | Method and apparatus for analyzing a test material by inducing and detecting light-matter interactions |
US6156010A (en) * | 1997-06-17 | 2000-12-05 | Injectimed, Inc. | Method and apparatus for introducing an intravenous catheter |
US6584335B1 (en) * | 1997-08-09 | 2003-06-24 | Roche Diagnostics Gmbh | Analytical device for in vivo analysis in the body of a patient |
US6299583B1 (en) * | 1998-03-17 | 2001-10-09 | Cardiox Corporation | Monitoring total circulating blood volume and cardiac output |
US6254586B1 (en) * | 1998-09-25 | 2001-07-03 | Minimed Inc. | Method and kit for supplying a fluid to a subcutaneous placement site |
US20070100356A1 (en) * | 1999-04-09 | 2007-05-03 | Evalve, Inc. | Delivery device, systems and methods of use |
US6273874B1 (en) * | 1999-08-18 | 2001-08-14 | Becton, Dickinson And Company | Protected peelable U-wing introducer |
US6663595B2 (en) * | 1999-12-23 | 2003-12-16 | Tfx Medical, Inc. | Peelable PTFE sheaths and methods for manufacture of same |
US20060079740A1 (en) * | 2000-05-15 | 2006-04-13 | Silver James H | Sensors for detecting substances indicative of stroke, ischemia, or myocardial infarction |
US20040006379A1 (en) * | 2000-10-06 | 2004-01-08 | Expanding Concepts, L.L.C. | Epidural thermal posterior annuloplasty |
US20060083688A1 (en) * | 2000-12-05 | 2006-04-20 | Bakthan Singaram | Optical determination of glucose utilizing boronic acid adducts |
US20020072661A1 (en) * | 2000-12-13 | 2002-06-13 | Wiesmann William P. | Minimally invasive system for assessment of organ function |
US6519485B2 (en) * | 2000-12-13 | 2003-02-11 | The General Hospital Corporation | Minimally invasive system for assessment of organ function |
US7945312B2 (en) * | 2001-09-04 | 2011-05-17 | Bioluminate, Inc. | Multisensor probe for tissue identification |
US20050267326A1 (en) * | 2001-10-02 | 2005-12-01 | Alfred E. Mann Institute For Biomedical Eng. At The University Of Southern California | Percutaneous chemical sensor based on fluorescence resonant energy transfer (FRET) |
US20030187589A1 (en) * | 2002-03-28 | 2003-10-02 | Kaoru Terashima | Humoral testing unit and a humoral testing apparatus |
US20040023317A1 (en) * | 2002-03-29 | 2004-02-05 | Board Of Regents Of The University Of Texas System | Implantable biosensor from stratified nanostructured membranes |
US20050054975A1 (en) * | 2002-09-24 | 2005-03-10 | Bhavesh Patel | Peripherally inserted central catheter with continuous central venous oximetry and proximal high flow port |
US20040111018A1 (en) * | 2002-12-09 | 2004-06-10 | Research and Education Institute | Conjunctival monitor |
US6973338B2 (en) * | 2002-12-09 | 2005-12-06 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Conjunctival monitor |
US7229450B1 (en) * | 2003-02-11 | 2007-06-12 | Pacesetter, Inc. | Kink resistant introducer with mapping capabilities |
US20040260162A1 (en) * | 2003-03-15 | 2004-12-23 | Daniel Rohleder | Analysis system for reagent-free determination of the concentration of an analyte in living tissue |
US7277740B2 (en) * | 2003-03-15 | 2007-10-02 | Roche Diagnostics Operations, Inc. | Analysis system for reagent-free determination of the concentration of an analyte in living tissue |
US7879024B2 (en) * | 2003-06-26 | 2011-02-01 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Splittable cannula having radiopaque marker |
US20040267203A1 (en) * | 2003-06-26 | 2004-12-30 | Potter Daniel J. | Splittable cannula having radiopaque marker |
US20050113658A1 (en) * | 2003-11-26 | 2005-05-26 | Becton, Dickinson And Company | Fiber optic device for sensing analytes and method of making same |
US20060189979A1 (en) * | 2005-02-23 | 2006-08-24 | Esch Brady D | Methods and apparatus for coagulating and/or constricting hollow anatomical structures |
US20090088609A1 (en) * | 2005-05-03 | 2009-04-02 | Thomas Schmitz-Rode | Method of taking internal physiological measurements |
WO2006117154A1 (en) * | 2005-05-03 | 2006-11-09 | Rheinisch-Westfälische Technische Hochschule Aachen | Device for detecting physiological measured variables within the body |
US20070081758A1 (en) * | 2005-09-29 | 2007-04-12 | Ichiro Tono | Optical waveguide type biochemical sensor chip and method of manufacturing the same |
US20090196864A1 (en) * | 2005-10-20 | 2009-08-06 | Bulla Lee A | Insecticides that target protein kinase a (pka) |
US20070244382A1 (en) * | 2005-11-15 | 2007-10-18 | Mark Ries Robinson | Blood Analyte Determinations |
US20080021294A1 (en) * | 2006-07-14 | 2008-01-24 | Levin Paul D | Disposable blood glucose sensor with internal pump |
US20080027245A1 (en) * | 2006-07-25 | 2008-01-31 | Glumetrics Inc. | Fluorescent dyes for use in glucose sensing |
US20080086042A1 (en) * | 2006-10-04 | 2008-04-10 | Dexcom, Inc. | Analyte sensor |
US20080212918A1 (en) * | 2007-03-02 | 2008-09-04 | Babin Steven M | Fiber Optic Sensor Device for Measuring Chromophoric Compounds in Biological Fluid |
US20090088615A1 (en) * | 2007-10-01 | 2009-04-02 | Mark Ries Robinson | Indwelling Fiber Optic Probe for Blood Glucose Measurements |
US8512245B2 (en) * | 2008-04-17 | 2013-08-20 | Glumetrics, Inc. | Sensor for percutaneous intravascular deployment without an indwelling cannula |
Non-Patent Citations (1)
Title |
---|
Implantable chmical sensors for real-time clinical monitoring: progress and challenges. Megan C Frost and Mark E Meyerhoff Chemical Biology 2002, 6:663-641 * |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11504063B2 (en) | 2017-06-23 | 2022-11-22 | Dexcom, Inc. | Transcutaneous analyte sensors, applicators therefor, and associated methods |
US11395631B2 (en) * | 2017-06-23 | 2022-07-26 | Dexcom, Inc. | Transcutaneous analyte sensors, applicators therefor, and associated methods |
US10905377B2 (en) | 2017-06-23 | 2021-02-02 | Dexcom, Inc. | Transcutaneous analyte sensors, applicators therefor, and associated methods |
US11510625B2 (en) | 2017-06-23 | 2022-11-29 | Dexcom, Inc. | Transcutaneous analyte sensors, applicators therefor, and associated methods |
US11311240B2 (en) | 2017-06-23 | 2022-04-26 | Dexcom, Inc. | Transcutaneous analyte sensors, applicators therefor, and associated methods |
US11207026B2 (en) | 2017-06-23 | 2021-12-28 | Dexcom, Inc. | Transcutaneous analyte sensors, applicators therefor, and associated methods |
US10863944B2 (en) | 2017-06-23 | 2020-12-15 | Dexcom, Inc. | Transcutaneous analyte sensors, applicators therefor, and associated methods |
US11311241B2 (en) | 2017-06-23 | 2022-04-26 | Dexcom, Inc. | Transcutaneous analyte sensors, applicators therefor, and associated methods |
US11134896B2 (en) | 2017-06-23 | 2021-10-05 | Dexcom, Inc. | Transcutaneous analyte sensors, applicators therefor, and associated methods |
US20180368774A1 (en) * | 2017-06-23 | 2018-12-27 | Dexcom, Inc. | Transcutaneous analyte sensors, applicators therefor, and associated methods |
US11331022B2 (en) | 2017-10-24 | 2022-05-17 | Dexcom, Inc. | Pre-connected analyte sensors |
US11382540B2 (en) | 2017-10-24 | 2022-07-12 | Dexcom, Inc. | Pre-connected analyte sensors |
US11350862B2 (en) | 2017-10-24 | 2022-06-07 | Dexcom, Inc. | Pre-connected analyte sensors |
US11706876B2 (en) | 2017-10-24 | 2023-07-18 | Dexcom, Inc. | Pre-connected analyte sensors |
US11943876B2 (en) | 2017-10-24 | 2024-03-26 | Dexcom, Inc. | Pre-connected analyte sensors |
USD926325S1 (en) | 2018-06-22 | 2021-07-27 | Dexcom, Inc. | Wearable medical monitoring device |
Also Published As
Publication number | Publication date |
---|---|
WO2009129186A2 (en) | 2009-10-22 |
US8512245B2 (en) | 2013-08-20 |
US20090264719A1 (en) | 2009-10-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8512245B2 (en) | Sensor for percutaneous intravascular deployment without an indwelling cannula | |
Poscia et al. | A microdialysis technique for continuous subcutaneous glucose monitoring in diabetic patients (part 1) | |
EP1973503B1 (en) | Oxygen sensor for internal monitoring of tissue oxygen in vivo | |
US8615281B2 (en) | Hypodermic optical monitoring of bodily analyte | |
US8467843B2 (en) | Optical sensor configuration for ratiometric correction of blood glucose measurement | |
US20100298764A1 (en) | Fluid delivery system with optical sensing of analyte concentration levels | |
US8694069B1 (en) | Fiber-optic probe with embedded peripheral sensors for in-situ continuous monitoring | |
Wickramasinghe et al. | Current problems and potential techniques in in vivo glucose monitoring | |
US20040260162A1 (en) | Analysis system for reagent-free determination of the concentration of an analyte in living tissue | |
WO2007058872A2 (en) | Detecting markers of stroke, ischemia, or myocardial infaction | |
EP0798981A1 (en) | Self-guiding, multifunctional visceral catheter | |
US20110263953A1 (en) | Deployment system and method for optical analyte sensor | |
US20120053427A1 (en) | Optical sensor configuration and methods for monitoring glucose activity in interstitial fluid | |
Pasic et al. | Miniaturized fiber-optic hybrid sensor for continuous glucose monitoring in subcutaneous tissue | |
US9757057B2 (en) | Dry insertion and one-point in vivo calibration of an optical analyte sensor | |
US20080214912A1 (en) | Blood Glucose Monitoring System And Method | |
US10610134B2 (en) | Methods and devices for analyte sensing in potential spaces | |
Volpe et al. | In vivo continuous monitoring of L-lactate coupling subcutaneous microdialysis and an electrochemical biocell | |
Ricci et al. | Ex vivo continuous glucose monitoring with microdialysis technique: The example of GlucoDay | |
De Boer et al. | In vivo monitoring of lactate and glucose with microdialysis and enzyme reactors in intensive care medicine | |
Rolfe | Review of chemical sensors for physiological measurement | |
Bartnik et al. | Advancements in optical fiber sensors for in vivo applications–A review of sensors tested on living organisms |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: MEDTRONIC MINIMED, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:GLUMETRICS, INC.;REEL/FRAME:033275/0803 Effective date: 20140320 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |